Simulated tissue structures and methods

Information

  • Patent Grant
  • 10354556
  • Patent Number
    10,354,556
  • Date Filed
    Friday, June 17, 2016
    7 years ago
  • Date Issued
    Tuesday, July 16, 2019
    4 years ago
Abstract
Simulated tissue structures and methods of manufacturing are provided. The simulated tissue structures are particularly useful for placement inside abdominal simulators for practicing laparoscopic surgical techniques. One simulated tissue structure includes a combination of two materials that are attached together wherein one of the materials forms a hollow anatomical structure configured to contain the other material. The two materials are attached in an anatomically advantageous manner such that the inner surface of the outer material closely conforms to the outer surface of the inner material. Another simulated tissue structure includes a plurality of layers wherein at least one layer is applied by printing the layer with at least one stencil to impart one or more functional characteristic to the simulated tissue structure.
Description
FIELD OF THE INVENTION

This application relates to surgical training tools, and in particular, to simulated tissue structures and organ models for teaching and practicing surgical procedures and methods for making them.


BACKGROUND OF THE INVENTION

A highly-skilled operation technique is required of surgeons, in general, and, in particular, for performing laparoscopic surgical procedures. In laparoscopic surgery, several small incisions are made in the abdomen for the insertion of trocars or small cylindrical tubes approximately 5 to 10 millimeters in diameter through which surgical instruments and a laparoscope are placed into the abdominal cavity. The laparoscope illuminates the surgical field and sends a magnified image from inside the body to a video monitor giving the surgeon a close-up view of organs and tissues. The surgeon performs the operation by manipulating the surgical instruments placed through the trocars while watching the live video feed on a monitor. Because the surgeon does not observe the organs and tissues directly with the naked eye, visual information is obtained by a two-dimensional image on a monitor instead of a three-dimensional observation. The loss of information when presenting a three-dimensional environment via a two-dimensional image is substantial. In particular, depth perception is reduced when viewing a two-dimensional image as a guide for manipulating instruments in three dimensions.


Furthermore, because the trocars are inserted through small incisions and rest against the abdominal wall, the manipulation of instruments is restricted by the abdominal wall which has a fulcrum effect on the instrument. The fulcrum effect defines a point of angulation that constrains the instrument to limited motion. Also, hand motion in one linear direction causes magnified tip motion in the opposite direction. Not only is the instrument motion viewed on the screen in the opposite direction, but also, the magnified tip motion is dependent on the fraction of the instrument length above the abdominal wall. This lever effect not only magnifies motion but also magnifies tool tip forces that are reflected to the user. Hence, the operation of an instrument with a fulcrum requires intentional learning and practice and is not intuitively obvious.


Also, surgical instruments are placed through ports having seals which induce a stick-slip friction caused by the reversal of tool directions. For example, stick-slip friction may arise from the reversal of tool directions when, for example, quickly changing from pulling to pushing on tissue. During such motion, rubber parts of the seals rub against the tool shaft causing friction or movement of the seal with the seal before the friction is overcome and the instrument slides relative to the seal. Stick-slip friction, or oil-canning, at the seal and instrument interface creates a non-linear force.


Hand-eye coordination skills are necessary and must be practiced in order to correlate hand motion with tool tip motion especially via observation on a video monitor. Also, in laparoscopic surgery, tactile sensation through the tool is diminished. Because haptics are reduced or distorted, the surgeon must develop a set of core haptic skills that underlie proficient laparoscopic surgery. The acquisition of all of these skills is one of the main challenges in laparoscopic training and the present invention is aimed at improving systems and methods for laparoscopic skills training and technique performance.


Not only do new practitioners have to learn laparoscopic skills, but also, experienced laparoscopic surgeons seek to polish old skills as well as to learn and practice new surgical techniques that are unique to newly introduced surgical procedures. While training can be acquired in the operating room, interest in devising faster and more efficient training methods, preferably outside the operating room has increased. Surgeons that attain a reasonable level of skills outside the operating room are better prepared when they enter the operating room and, thereby, valuable operating room experience can thus be optimized, lowering the risk to patients and reducing costs. To acquaint surgeons with basic surgical skills outside the operating room, various simulators have been devised and tested. An example of a surgical simulator is the SIMSEI® laparoscopic trainer manufactured by Applied Medical Resources Corporation in California and described in U.S. Pat. No. 8,764,452 incorporated by reference herein in its entirety. The SIMSEI® laparoscopic trainer employs three-dimensional live or fake organs inside a simulated abdominal cavity that is obscured from direct observation by the user.


Use of a live human or animal organ in a laparoscopic simulator requires freshness for the internal organ. Also, live organs require sanitary arrangements to be made to protect the trainee from being infected by germs and the like. Additional costs are also required for the sanitary management and sterilization of instruments which are used after the exercise of a surgical operation is performed. Also, the used live organ must be properly disposed. Furthermore, the smell of a live organ can be fowl and may distract the trainee from focusing on techniques and skills. Therefore, artificial organs and tissues that simulate live organs and tissues are desirable so that live organs can be replaced in surgical training.


Many artificial organs have been used in place of live human or animal organs in surgical training. Typically, these artificial organ models are made of silicone, urethane elastomer, styrene elastomer or the like. These artificial organs must respond properly when incised, manipulated or sutured, for example, and provide the same feeling and tactile characteristics as in real life surgery. However, many artificial organs lack certain properties and realism that are necessary to bridge the gap between artificial and real organs. Furthermore, the degree of realism must be targeting to provide means for teaching the skills that are peculiar to laparoscopic skills training. As such, certain realisms may be more important in a laparoscopic environment when compared to an open surgical environment. Therefore, there is a need for artificial organs and tissues and, in particular, for artificial organs and tissues that are targeted for laparoscopic skills training. The present invention sets forth new artificial organs and tissues that are realistic and targeted for laparoscopic skills training. The present invention also provides the methods of manufacturing such artificial organs and tissues.


SUMMARY OF THE INVENTION

According to one aspect of the invention, a simulated tissue structure and method of manufacturing it are provided. The simulated tissue structure includes a combination of two materials that are attached together wherein one of the materials forms a hollow anatomical structure configured to contain the other material. The two materials are attached in an anatomically advantageous manner such that the inner surface of the outer material closely conforms to the outer surface of the other. Also, the internal material has a different and more rigid characteristic relative to the external material and the anatomical geometry formed by the outer material would normally make insertion of the internal material into the external geometry damaging to the outer geometry, difficult to accomplish and would reduce the realism arising from compensations, such as repairing and gluing, necessary due to damaging insertion. The method of manufacture of the present invention includes the step of applying a first material in an uncured state directly onto the second material in a solid state to encase or encompass in whole or in part the second material; the second material defines the size and shape of at least part of the first material and forms a unitary and connected construction with the first material that is also easy to remove from a mandrel.


According to another aspect of the invention, a method of making a simulated tissue structure is provided. The method includes the step of providing a mandrel having a proximal end, a distal end and a longitudinal axis wherein the distal end of the mandrel includes an interlocking portion having a length. The method includes the step of providing an inner portion of a simulated tissue structure. The inner portion has a lumen sized and configured to receive the interlocking portion such that the entire length of the interlocking portion is located inside the lumen. The method includes the step of placing the inner portion onto the mandrel. The method further includes the step of placing the interlocking portion of the mandrel into the lumen of the inner portion. The method includes the steps of rotating the mandrel about the longitudinal axis, applying uncured silicone onto the inner portion, curing the silicone to form an outer portion that surrounds the inner portion, and removing the inner portion and the outer portion as one unit from the mandrel.


According to another aspect of the invention, a method of making a simulated tissue structure is provided. The method includes the step of providing a simulated anatomical structure. The method includes the step of providing a mandrel having a longitudinal axis, a proximal end and a distal end. The mandrel is configured to removably attach to the simulated anatomical structure. The method includes the step of connecting the simulated anatomical structure to the mandrel at a location along the longitudinal axis. The method includes the step of rotating the mandrel and connected simulated anatomical structure. The method includes the step of applying a second material in an uncured state to the mandrel and to the simulated anatomical structure. The method includes the step of allowing the second material to cure onto the simulated anatomical structure and mandrel to form a simulated tissue structure in which the simulated anatomical structure is surrounded in a thin shell of the second material. The simulated tissue structure has at least one lumen defined by the second material cured onto the mandrel. The method includes the steps of attaching the second material to the simulated anatomical structure, and removing the simulated anatomical structure with the attached second material.


According to another aspect of the invention, a simulated tissue structure is provided. The simulated anatomical structure has a proximal end and a distal end of a first material located inside a thin shell of a second material having a proximal end and a distal end. The simulated anatomical structure is attached to the second material. The simulated anatomical structure has a first diameter and a first lumen at the proximal end and the second material has a second lumen having a second diameter at the proximal end wherein the first lumen is substantially aligned with the second lumen.


According to another aspect of the invention, a method of making a simulated tissue structure is provided. The method includes the step of providing a planar first base layer. The method includes the step of providing a first stencil having at least one hole, and applying the first stencil onto the first base layer. The method includes the step of applying a first stencil layer onto the first base layer via the first stencil. The method includes the steps of removing the first stencil, providing a planar second base layer, and applying a second base layer over the stencil layer and first base layer. The method further includes the step of adhering the second base layer to the first base layer.


According to another aspect of the invention, a simulated tissue structure is provided. The simulated tissue structure includes a planar first base layer having a first side and a second side defining a substantially uniform thickness therebetween. The simulated tissue structure includes a planar second base layer having a first side and a second side defining a substantially uniform thickness therebetween. The second side of the second base layer faces the first side of the first base layer. The second base layer is adhered to the first base layer. The simulated tissue structure further includes at least one functional layer comprising a functional material located between the first base layer and the second base layer wherein the functional layer is formed via a stencil having at least one hole for applying the functional material.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1A is a top perspective, transparent view of a simulated tissue structure comprising an inner portion and an outer portion wherein the outer portion forms an artificial fallopian tube and the inner portion forms an ectopic pregnancy according to the present invention.



FIG. 1B is a top perspective, transparent view of a simulated tissue structure comprising an inner portion and an outer portion wherein the outer portion forms an artificial fallopian tube and the inner portion forms an ectopic pregnancy according to the present invention.



FIG. 1C is a top perspective, cross-sectional view of a simulated tissue structure comprising an inner portion and an outer portion wherein the outer portion forms an artificial fallopian tube and the inner portion forms an ectopic pregnancy according to the present invention.



FIG. 1D is a top perspective, cross-sectional view of a simulated tissue structure comprising an inner portion and an outer portion wherein the outer portion forms an artificial fallopian tube and the inner portion forms an ectopic pregnancy according to the present invention.



FIG. 2A is a top perspective view of an inner portion of FIG. 1 according to the present invention.



FIG. 2B is a top view of an inner portion of FIG. 1 according to the present invention.



FIG. 2C is a side view of an inner portion of FIG. 1 according to the present invention.



FIG. 2D is a bottom view of an inner portion of FIG. 1 according to the present invention.



FIG. 3A is an exploded, top perspective view of an inner portion, an outer portion, adapter and mandrel according to the present invention.



FIG. 3B is a top perspective view of an inner portion, outer portion adapter and mandrel according to the present invention.



FIG. 3D is a top perspective, cross-sectional view of an inner portion and outer portion according to the present invention.



FIG. 3E is a top perspective, partial cross-sectional view of an inner portion and outer portion according to the present invention.



FIG. 4 is top perspective view of a mandrel according to the present invention.



FIG. 5 is a top perspective view of a portion of a mandrel and inner portion according to the present invention.



FIG. 6 is a top perspective view of a portion of a mandrel and inner portion according to the present invention.



FIG. 7A is a top perspective view of an inner portion according to the present invention.



FIG. 7B is a top view of an inner portion according to the present invention.



FIG. 7C is a side view of an inner portion according to the present invention.



FIG. 7D is a side view of an inner portion according to the present invention.



FIG. 8 is top perspective view of a mandrel according to the present invention.



FIG. 9 is a top perspective view of a portion of a mandrel and inner portion according to the present invention.



FIG. 10 is a top perspective view of a portion of a mandrel and inner portion according to the present invention.



FIG. 11 is a top perspective, cross-sectional view of a simulated tissue structure according to the present invention.



FIG. 12 is a top perspective view of an inner portion and a mandrel according to the present invention.



FIG. 13 is a top perspective, cross-sectional view of a simulated tissue structure according to the present invention.



FIG. 14A is a top perspective, partial sectional view of a simulated tissue structure according to the present invention.



FIG. 14B is a top perspective, partial sectional, transparent view of a simulated tissue structure according to the present invention.



FIG. 15 is top view of a stencil according to the present invention.



FIG. 16 is a top view of a stencil according to the present invention.



FIG. 17 is a top view of a stencil according to the present invention.



FIG. 18 is a top view of a stencil according to the present invention.



FIG. 19 is a top perspective view of a stencil and a portion of a simulated tissue structure according to the present invention.



FIG. 20 is a top perspective view of a stencil and a portion of a simulated tissue structure according to the present invention.



FIG. 21 is top perspective view of a simulated tissue structure according to the present invention.



FIG. 22 is a top perspective, sectional view of a portion of a stimulated tissue structure according to the present invention.



FIG. 23 is a top perspective, sectional view of a portion of a simulated tissue structure and a stencil according to the present invention.



FIG. 24 is a top perspective, sectional view of a simulated tissue structure according to the present invention.



FIG. 25 is a top perspective, sectional view of a portion of a simulated tissue structure according to the present invention.



FIG. 26 is a top perspective, sectional view of a simulated tissue structure according to the present invention.



FIG. 27 is a top perspective, transparent, sectional view of a simulated tissue structure according to the present invention.



FIG. 28 is a top perspective view of a stencil according to the present invention.



FIG. 29 is a top perspective view of a base layer and stencil according to the present invention.



FIG. 30 is a top perspective view of a first base layer and first stencil layer according to the present invention.



FIG. 31 is a top perspective, sectional view of a first base layer, first stencil layer and a second base layer according to the present invention.



FIG. 32 is a top perspective, sectional view of a first base layer, first stencil layer, a second base layer and a second stencil according to the present invention.



FIG. 33 is a top perspective, sectional view of a first base layer, a first stencil layer, a second base layer and a second stencil layer according to the present invention.



FIG. 34 is a top perspective, sectional view of a first base layer, a first stencil layer, second base layer, second stencil layer and third base layer according to the present invention.



FIG. 35 is a is a top perspective, sectional view of a first base layer, a first stencil layer, second base layer, second stencil layer, third base layer, and third stencil according to the present invention.



FIG. 36 is a is a top perspective, sectional view of a first base layer, a first stencil layer, second base layer, second stencil layer, third base layer, and third stencil layer according to the present invention.



FIG. 37 is a top perspective, sectional view of a simulated tissue structure according to the present invention.



FIG. 38 is a top perspective, transparent, sectional view of a simulated tissue structure according to the present invention.



FIG. 39 is a top perspective, transparent sectional view of a simulated tissue structure according to the present invention.





DETAILED DESCRIPTION OF THE INVENTION

Turning now to FIGS. 1A-1D, there is shown a simulated tissue structure 10 according to the present invention. The simulated tissue structure 10 includes a silicone outer portion 12 having an outer surface and an inner surface. The inner surface defines an interior cavity 14. The interior cavity 14 is interconnected with at least one opening 16. The cavity 14 of the simulated tissue structure 10 of FIGS. 1A-1D includes two openings 16 and the cavity 14 is lumen-like and generally elongated. In particular, the outer portion 12 is configured to have a size and shape of a tissue structure, organ, or at least a part of an anatomy. For example, as shown in FIGS. 1A-1D, the outer portion 12 is configured in shape and size to represent a fallopian tube of the female human anatomy. FIGS. 1B and 1C illustrate a proximal elongation that is longer so as to integrally form a fallopian tube than shown in FIGS. 1A and 1C so as to be optionally connectable to a separately formed fallopian tube extension. The proximal opening 16 can be connected to an artificial uterus and/or a separately formed fallopian tube extension and the distal opening 16 includes longitudinal cuts to mimic the fallopian tube. The outer portion 12 is made of silicone such as platinum cured room temperature vulcanization silicone (PCRTVS). The outer portion 12 can also be made of any other type of silicone material, polymer, rubber, elastomer and the like.


The simulated tissue structure 10 further includes an inner portion 18 that is located inside the cavity 14 of the outer portion 12. The inner portion 18 includes an outer surface and an inner surface. The inner surface of the outer portion 12 closely conforms to the outer surface of the inner portion 18. The foam inner portion 18 is connected to the outer portion 12. In the variation shown in FIGS. 1A-1D, the foam inner portion 18 is connected to the outer portion 12 near the proximal end of the fallopian tube and is configured to represent an ectopic pregnancy and as such is dark in color such as black or brown. The inner portion 18 is made of foam material. The foam material can be urethane foam, silicone foam or any other suitable foam. If urethane foam is used for the inner portion 18, the silicone outer portion 12 will not stick as much to the urethane foam and the silicone outer portion 12 will be more easily removable relative to the inner portion 18 making it advantageous for facilitating and simulating surgical removal of the simulated ectopic pregnancy. If silicone foam is used for the inner portion 18, the silicone outer portion 12 will stick more to the silicone foam inner portion 18 and the silicone outer portion 12 will be harder to remove relative to the inner portion 18 making it advantageous for increasing the level of difficulty and surgical skill required in removing the simulated ectopic pregnancy. The inner portion 18 has a longitudinal axis, an outer perimeter and a width or outer diameter defined by the outer perimeter measured perpendicular to the longitudinal axis. The outer diameter of the inner portion 18 is equal to or less than the width or inner diameter of the outer portion at the same position along the longitudinal axis. The length of the inner portion 18 is shorter than the outer portion 12 along the longitudinal axis. The outer portion 12 at a location either proximal to the proximal end of the inner portion 18 or distal to the distal end of the inner portion 18 has a width or inner diameter that is smaller than the width or outer diameter of the proximal end of the inner portion or has a width or inner diameter that is smaller than the width or outer diameter of the distal end of the inner portion, respectively. In another variation as shown in FIGS. 1A-1D, the outer portion 12 at a location proximal to the proximal end of the inner portion 18 and distal to the distal end of the inner portion 18 has a width or inner diameter that is smaller than the width or outer diameter of the proximal end of the inner portion and has a width or inner diameter that is smaller than the width or outer diameter of the distal end of the inner portion, respectively. Such a configuration, encapsulates the inner portion 18 within the outer portion preventing its migration along the longitudinal direction. The inner portion 18 is captured between constrictions in the outer portion at opposite ends of the inner portion.


Turning now to FIGS. 2A-2D, there is shown various views of an inner portion 18 made of foam material. The inner portion 18 has an outer surface and an inner surface. The outer surface is bulbous in shape. The inner portion 18 includes a lumen 20 defined by the inner surface. The lumen 20 extends between a proximal opening 22 at the proximal end and a distal opening 24 at the distal end. The lumen 20 is configured to fit over a mandrel. As such, at least part of the lumen 20 has a non-circular cross-section so that inner portion 18 does not move with respect to the mandrel when the mandrel rotates. The cross-sectional shape of the lumen 20 is hexagonal although the invention is not so limited and the cross-section can be elongate, a slot, triangular, square, pentagonal or any other shape that keeps the foam inner portion from spinning freely while on the mandrel. Means other than the cross-sectional shape of the lumen 20, such a pin or other locking device, can be employed to secure the foam inner portion 18 to the mandrel 20.


Alternatively, and turning now to FIGS. 3A-3E, the inner portion 18 may or may not have a lumen 20 configured to mount onto a mandrel. Instead, the inner portion 18 is formed with a male boss 26 as shown in FIGS. 3A-3E. The male boss 26 includes an outer surface that has a non-circular cross-section. The cross-section of the male boss 26 taken perpendicular to the longitudinal axis is elongate, a slot, triangular, square, pentagonal, hexagonal or any other shape that keeps the inner portion from spinning freely while on the mandrel 30. The mandrel 30 is a standard elongate cylindrical rod with a circular cross-section as shown in FIGS. 3A-3C. An adapter 28 is provided and configured to connect to the distal end of the mandrel 30. The adapter 28 includes a female boss 32 having a shaped that is sized and configured for receiving the male boss 26 of the inner portion 18 to secure the inner portion 18 to the mandrel 30 such that the inner portion 18 does not rotate relative the mandrel 30 during the manufacturing process when the mandrel 30 is rotating. The foam inner portion 18 and the mandrel 30 are configured to have interlocking geometry between the mandrel 30 and the inner portion 18. The geometry is achieved during the design process and is incorporated into the molds used to manufacture both the forming mandrels and the foam inner portion 18. The shape between the two can be any geometry that keeps the components from freely spinning on each other. FIGS. 3D-3E shows the outer portion 12 connected to the inner portion 18 in a final product removed from the mandrel 30.


The method of manufacturing the simulated tissue structure 10 will now be described. A mandrel 30 is used to manufacture the simulated anatomy. The mandrel 30 is typically connected to motor that rotates the mandrel 30 about its longitudinal axis. A mold, typically a mold having a desired shape such as a shape of an anatomical portion to be formed, is attached to the mandrel 30. When the motor is turned on, the mandrel 30 rotates and uncured silicone such as uncured PCRTVS is applied to the rotating mold that is connected to the mandrel 30. As the uncured silicone begins to cure, it assumes the shape of the underlying mold. Uncured silicone is applied such as by painting layers, spraying, or dipping the mold. When the application of silicone is completed, the uncured silicone is allowed to cure and then the resulting simulated tissue structure 10 is removed from mold and the mandrel 30 to create a hollow tissue structure of a desired shape. Typical hollow organs that can be created using this method include rectums, ovaries, fallopian tubes, vasculature, uteri and other organs.


Turning now to FIG. 4, there is shown a mandrel 30 according to the present invention. The mandrel 30 is an elongate cylindrical rod having a circular cross-section at the proximal end or other-shaped proximal end configured for connection to a motor. At least part of the mandrel 30, the interlocking portion 36, is configured to interlock with a pre-formed foam inner portion 18. The interlocking portion 36 is configured to be inserted into a complementary-shaped lumen 20 of the foam inner portion 18. In one variation, the interlocking portion 36 has a hexagonal cross-section that is sized to fit inside a lumen 20 having a hexagonal cross-section. The foam inner portion 18 is designed to be part of the final simulated tissue structure 10. In one variation of the mandrel 30, the mandrel 30 includes at least one anatomical portion 38. In the variation shown in FIG. 4, the anatomical portion 38 is located at the distal end of the mandrel 30 and the interlocking portion 36 is located proximal to the anatomical portion 38 along the longitudinal axis and the cylindrical portion of the mandrel 30 is located proximal to the interlocking portion 36. The anatomical portion 38 is configured to represent at least part of an anatomy. In particular, the anatomical portion 38 is configured to mimic a hollow part of an anatomy. In FIG. 4, the anatomical portion 38 is configured to simulate a fallopian tube or distal end of a fallopian tube of a female human anatomy. As such, the anatomical portion 38 is curved and has a larger diameter distal end. The anatomical portion 38 is connected to the mandrel 30 at a location distal to the interlocking portion 36 although the invention is not so limited and the interlocking portion may be located in between two anatomical portions 38 or be formed as part of the anatomical portion 38. The portion of the mandrel 30 that is proximal to the interlocking portion 36 also serves as a second or proximal anatomical portion 38 such as the proximal end of a fallopian tube.


Turning now to FIG. 5, there is shown a mandrel 30 in juxtaposition with an inner portion 18 according to the present invention. The inner portion 18 of FIG. 5 is shaped like an ectopic pregnancy of FIGS. 2A-2D. The proximal end 34 of the mandrel 30 is inserted into the distal opening 24 of the lumen 20 of the inner portion 18. The inner portion 18 is moved along the cylindrical portion of the mandrel 30 toward the interlocking portion 36. The inner portion 18 slides along the longitudinal axis of the mandrel 30. The hexagonal shape of the interlocking portion 36 of the mandrel 30 is aligned with the hexagonal shape of the lumen 20 of the inner portion 18 and the interlocking portion 36 of the mandrel 30 is inserted into the lumen 20 of the inner portion 18. The inner portion 18 securely locks onto the mandrel 30 with a slight interference fit which prevents it from rotating relative to the mandrel 30 or easily sliding distally or proximally along the mandrel 30. The mandrel 30 is connected to the inner portion 18 in the location of the interlocking portion 36 via an interference fit as shown in FIG. 6. The mandrel 30 and the attached inner portion 18 are then connected to a motor (not shown) configured to receive and connect with the proximal end of the mandrel 30. The motor is configured to rotate the mandrel 30 and the attached inner portion 18 about its longitudinal axis.


As the mandrel 30 and attached inner portion 18 is rotated, uncured silicone such as PCRTVS is applied to cover at least the anatomical portion 38A and inner portion 18 and where applicable, a second anatomical portion 38B that is proximal to the interlocking portion 36 as shown in FIG. 6. As the mandrel 30 rotates, more uncured silicone is applied to achieve a desired thickness of material that will form the outer portion 12. The uncured silicone begins to cure and additional uncured silicone can be continuously applied. The uncured silicone is applied on and over the mandrel 30 and inner portion 18 together. Uncured silicone may be applied with a brush, spray, by dipping or other manner. Rotation of the mandrel 30 prevents the silicone from curing to form unevenly covered areas. After the silicone is cured, the outer portion 12 is formed comprising the silicone layer about the mandrel 30. Hence, the outer surface of the inner portion 18 will define the size and shape of at least part of the inner surface of the outer portion 12 and the outer surface of the anatomical portion 38 will define the size and shape of at least part of the inner surface of the outer portion 12 in a substantially continuous manner such that both the inner portion 18 and the anatomical portion(s) 38 define the size and shape of the outer portion 12. The anatomical portion 38 is adjacent to the inner portion 18 located on the mandrel 30 and the outer portion of uncured silicone is applied to both in a seamless way to form a unitary simulated tissue structure 10. The inner portion 18 is removable from the mandrel 30 together with the outer portion 18 whereas the anatomical portion 38 of the mandrel 30 remains fixed to the mandrel 30. Hence, uncured silicone is applied to the inner portion 18 that is removable from the mandrel 30 and becomes integral with and attached to the outer portion 12 wherein the anatomical portion 38 which serves as a mold for at least another portion of the outer portion 12 is not removable from the mandrel 30 at least when the outer portion 12 and inner portion 18 are being removed.


Once the silicone cures, the outer portion 12 on the second anatomical portion 38B is rolled along the mandrel 30 towards the inner portion 18 or proximal end of the mandrel 30 and then the inner portion 18 and silicone outer portion 12 can be easily removed from the mandrel 30 as a single unit. The rolling of proximal end of the outer portion 12 helps to relieve any frictional forces between the outer portion 12 and the mandrel 30 to facilitate removal of the final anatomical model. As explained earlier, if the inner portion 18 is made of silicone foam then the uncured silicone will, as it cures, interlock, attach and connect with the silicone foam more strongly than if the inner portion 18 was made of urethane foam. This stronger bond will help in removing the silicone outer layer 12 and the attached inner portion 18 together more easily. Mold release or resist can be applied to the anatomical portion 38 and cylindrical portion of the mandrel 30 to facilitate removal of the outer portion 12 and inner portion 18 resulting in the simulated tissue structure 10 of FIG. 1.


This method can be used to make fallopian tubes with ectopic pregnancies as just described above wherein the inner portion 18 simulates an ectopic pregnancy and the silicone outer portion 12 simulates the fallopian tube. The process can be used to make a wide range of other anatomies. The method adapted for making ovaries and ovaries with cysts with fallopian tubes will be described hereinbelow. Other anatomies that can be simulated include healthy and fibroid uteri. The foam of the inner portion 18 can be rigid or flexible and, as described above, it can be made of urethane, silicone or other material. Also, the simulated tissue could be any material other than silicone that can be applied to a mandrel by dipping, painting, spraying, etc.


Also, the method can be combined with a the steps of providing a mesh sleeve, for example, made of nylon mesh, placing the mesh sleeve onto the mandrel 30 and, applying the material of the outer portion 12 such as uncured silicone. The uncured silicone if applied to the mesh will pour over the mesh material and cure integrally into the mesh. Similarly, mesh applied to uncured silicone will cure integrally together. The mesh advantageously makes the outer portion 12 capable of holding sutures for the practice of suturing certain anatomies.


Turning now to FIGS. 7A-7D, there is shown various views of an inner portion 18 made of foam material. The inner portion 18 has an outer surface and an inner surface. The outer surface is bulbous in shape and configured to represent a human female ovary. The inner portion 18 includes a lumen 20 defined by the inner surface. The lumen 20 extends from the proximal opening 22 at the proximal end into the inner portion 18. The lumen 20 does not extend through the inner portion 18 and only has one opening 22 at the proximal end. The lumen 20 is configured to fit over a mandrel 30. As such, at least part of the lumen 20 has a non-circular cross-section so that inner portion 18 does not move with respect to the mandrel 30 when inner portion 18 is mounted on the mandrel 30 and the mandrel 30 rotates. The cross-sectional shape of the lumen 20 is hexagonal although the invention is not so limited and the cross-section can be elongate, a slot, triangular, square, pentagonal or any other shape that keeps the inner foam portion 18 from spinning freely while on the mandrel 30. Means other than the cross-sectional shape of the lumen 20, such as a pin or lock, can be employed to secure the foam inner portion 18 to the mandrel 20. Of course, the inner portion 18 may or may not have a lumen 20 configured to mount onto a mandrel. Alternatively, the inner portion 18 is formed with a male boss 26 as shown in FIGS. 3A-3C for connecting the inner portion 18 to the mandrel 30. The inner portion 18 of FIGS. 7A-7D Includes two flatter outer surfaces interconnected by two curved side surfaces. The shape of the cross-section taken perpendicular to the longitudinal axis of the inner portion 18 is oval, elliptical, elongated or otherwise has a longer length relative to its width. The outer surface of the inner portion 18 includes a dimple 40. The dimple 40 is a concavity formed in the outer surface of the inner portion 18. The dimple 40 is sized and configured to receive an artificial cyst, fibroid, or tumor (not shown). The artificial cyst, fibroid or tumor 42 is separately made to simulate a real cyst, fibroid or tumor and sized and configured to fit inside the dimple 40. The artificial cyst, fibroid or tumor can be made of silicone or foam and can be appropriately dyed to accurately represent the respective structure. The artificial cyst, fibroid or tumor 42 is placed with some adhesive if necessary into the dimple 40 and uncured silicone of the outer portion 12 is then applied to both the dimple insert and the inner portion 18. In another variation, dimples 40 are not provided and simulated cysts 42 are attached directly to the outer surface of the inner portion 18. In yet another variation, the simulated cysts 42 are formed integrally with the inner portion 18 and optionally of the same material as the inner portion 18.


Turning now to FIG. 8, there is shown a mandrel 30 according to the present invention. The mandrel 30 is an elongate cylindrical rod having a circular cross-section. The mandrel 30 includes an interlocking portion 36 configured to interlock with a pre-formed foam inner portion 18. In one variation shown in FIG. 8, the mandrel 30 includes an interlocking portion 36 located at the distal end 34 of the mandrel 30. The interlocking portion 36 is configured to be inserted into a complementary-shaped lumen 20 of the foam inner portion 18. In one variation, the interlocking portion 36 has a hexagonal cross-section that is sized to fit inside a lumen 20 having a hexagonal cross-section. The foam inner portion 18 is designed to be part of the final simulated tissue structure 10.


Turning now to FIG. 9, there is shown a mandrel 30 in juxtaposition with an inner portion 18 according to the present invention. The inner portion 18 of FIG. 9 is shaped like an ovary of FIGS. 7A-7D. The distal end 34 of the mandrel 30 is inserted into the proximal opening 22 of the lumen 20 of the inner portion 18. The hexagonal shape of the distal end 34 of the mandrel 30 is aligned with the hexagonal shape of the lumen 20 of the inner portion 18 and the interlocking portion 36 of the mandrel 30 is inserted into the lumen 20 of the inner portion 18. The inner portion 18 securely locks onto the mandrel 30 with a slight interference fit. The mandrel 30 connected to the inner portion 18 via an interference fit is shown in FIG. 10. The mandrel 30 and the attached inner portion 18 are then connected to a motor (not shown) configured to receive and connect with the proximal end of the mandrel 30. The motor is configured to rotate the mandrel 30 and the attached inner portion 18 about its longitudinal axis.


A simulated cyst, tumor or other anatomical variation is placed in the dimple 40 and attached thereto or held in place with adhesive or with the simultaneous application of wet silicone constituting the outer portion 18. As the mandrel 30 and attached inner portion 18 and attached cysts are rotated uncured silicone, such as PCRTVS, is applied to cover at least the inner portion 18 and attached cysts. As the mandrel 30 rotates, more uncured silicone is applied to achieve a desired thickness of material. The uncured silicone begins to cure and additional uncured silicone can be continuously applied. The uncured silicone is applied on the inner portion 18 and may also be applied on the mandrel 30. Uncured silicone may be applied with by painting with a brush, spraying, dipping or other manner. Rotation of the mandrel 30 prevents the silicone from curing to form unevenly covered areas. After the silicone is completely cured, the outer portion 12 is formed comprising the silicone layer about the mandrel 30. Hence, the outer surface of the inner portion 18 will define the size and shape of at least part of the inner surface of the outer portion 12. Once the silicone cures, a portion of it at the mandrel 30 may be rolled distally along the longitudinal axis. The inner portion 18 may be grasped and pulled distally to remove the construct from the mandrel 30. The foam inner portion 18 and silicone outer portion 12 can be easily removed from the mandrel 30 as a single unit. The resulting simulated tissue structure 10 as removed from the mandrel 30 is illustrated in FIG. 11. As explained earlier, if the inner portion 18 is made of silicone foam, then the uncured silicone will, as it cures, interlock and connect with the silicone foam more strongly than if the inner portion 18 was made of urethane foam. This stronger bond will help in removing the silicone outer layer 12 and the attached inner portion 18 as a unit more easily. Mold release or resist can be applied to the mandrel 30 to facilitate removal of the outer portion 12 and inner portion 18 together resulting in the simulated tissue structure 10.


Turning now to FIG. 12, there is shown another variation in which an inner portion 18 is sized and configured to resemble a uterus. The inner portion 18 is shown with one or more simulated cysts 42 attached to the inner portion 18 in the location of dimples 40 if dimples 40 are provided for seating the simulated cysts 42. It should be noted that simulated cysts are used interchangeably with tumor, fibroid, or other similar anatomical or general surgical target throughout the specification. The inner portion 18 includes a lumen 20 opening at the proximal end. The lumen 20 is sized and configured such that the inner portion 18 does not rotate relative to the mandrel 30. The mandrel 30 is shorter such that the proximal end of the resulting simulated tissue structure 10 is shaped substantially realistically. The same methods described above are utilized to form the resulting structure 10 shown in FIG. 13 in which the simulated tumors 42 are embedded between the outer portion 12 and the inner portion 18. The lumen 20 at the proximal end of the simulated tissue structure 10 simulates the uterine canal and since the inner portion 18 is made of foam a practitioner is able to grasp and pull on the simulated tissue structure during the simulated surgery without risk of tearing as would likely be the case if the inner portion made of silicone, for example. The practitioner will approach the target cysts 42 and cut through the outer portion 12 and dissect the cysts 42 from the simulated uterus 10.


The present invention creates a simulated tissue structure 10 that advantageously combines silicone material with foam material that are attached in an anatomically advantageous manner to represent ectopic pregnancies, cysts, fibroids, tumors or other anatomical portion in combination with a hollow anatomical structure. The method includes applying silicone directly onto the inner portion to form the outer portion and simultaneously mold the outer portion to the inner portion in an integral fashion to form a unitary construction. Otherwise, the silicone outer portion would have to be formed separately on a mandrel and removed once cured. Then, the formed hollow silicone structure would have to be cut open and a foam piece would then be inserted into the silicone structure. Cutting open the silicone structure would be the only way to accommodate a size and shape of foam material while retaining the anatomical characteristics such as narrowed tubular structures on one or more ends of the foam inner portion. After the foam inner portion is inserted, the cut silicone would then have to be glued back together to complete the anatomy in question creating an inferior simulated tissue structure. By using the foam inner portion 18 as part of the forming mandrel 30 that is removable and integrated into the simulated tissue structure, the present invention advantageously eliminates several steps in the manufacturing process including cutting open a hollow silicone shape, inserting a foam inner piece into the opening created by the cutting, and then gluing the opening closed when finished. Cutting the hollow shape is necessitated by the size of the inner portion relative to the surrounding tubular anatomical structure. Forcing a foam insert in through an opening in the hollow silicone shape would result in the silicone tearing during the process. Hence, the present invention solves many problems to create an ideal simulated tissue structure. Furthermore, removal of silicone material from a mandrel 30 is complicated because the silicone is notoriously sticky and complex shapes such as fallopian tubes with ectopic pregnancy can be exceedingly difficult to remove from the mandrel without incurring damage to the work-piece. The addition of the foam insert to the mandrel greatly reduces the difficult of removing the silicone part from the mandrel because part of the silicone part is attached to the foam insert which easily slides off the mandrel instead of to the mandrel directly. Portions of silicone attached to an anatomical portion 30 or cylindrical portion of the mandrel 30 can be first bunched near the foam inner portion and then the inner portion 18 can easily slide off of the mandrel 30. As previously mentioned, the foam can represent a separate component entirely such as a cyst, fibroid or tumor or just serve as a filler material or tissue layer of different density to help certain anatomy to retain a three-dimensional shape or define and replicate certain anatomical characteristics. Additionally, having the silicone cure on the foam adds an element of difficulty to simulated training procedures which can be desirable in certain situations as dissection between tissue planes is not always easy. The present invention provides a simulated tissue structure with all of these advantages. Also, as mentioned previously, variants can include different material selection for the inner portion 18 including varying densities of foam and plastics can be used depending on the desired feel of the anatomical component.


The simulated tissue structure 10 of the present invention is particularly suited for laparoscopic procedures and may be employed with a laparoscopic trainer; however, the invention is not so limited and the simulated tissue structure 10 of the present invention can be used alone to practice various surgical procedures equally effectively.


Turning now to FIGS. 14A-14B, there is shown a simulated tissue structure 110 according to the present invention. The simulated tissue structure 110 includes at least a first layer 112 and a second layer 114 and at least one screen or stencil layer 115 located between the first layer 112 and second layer 114. The first layer 112 and the second layer 114 are typically made of silicone and formed into planar sheets with each layer having a first side and a second side and defining a substantially uniform thickness therebetween. The first and second layers 112, 114 are substantially identical and planar and, in one variation, at least one of the first and second layers 112, 114 is transparent or translucent such that the at least one screen layer 116 that is located between the first layer 112 and the second layer 114 is visible through the one of the first and second layers 114, 116. The screen layer 116 comprises an application of resist, release, adhesive, silicone, hydrogel or other material that is applied using a screen, stencil, plate, mask or other image transfer method. FIGS. 14A-14B, in particular, illustrate three layers of silicone and a total of two screen layers located between the three layers of silicone wherein each screen layer is located between two adjacent silicone layers. The process of making the simulated tissue structure 110 involves casting sheets of silicone or other elastomeric material to form the base layers and using a screen, stencil, or other image transfer method to apply a resist, adhesive, silicone or other material to form the functional stencil layers, the functional layer being applied to a cured base layer which is then overlaid with an uncured base layer and repeating the process after the uncured base layer has cured to build up a thickness of material with desired properties for surgical simulation.


One version of this process involves using a stencil to apply mold release or resist to silicone sheets in a desired pattern. By using stencils, screens, or lithographic plates, resist coverage can be tailored in a specific pattern such as dots, halftone or other pattern to give a specific area a percentage of adhesion or relative adhesion between two sheets of material. For example, if a stencil includes a pattern that is approximately 50% open and it is used to apply a stencil layer of resist material to a silicone layer of equal area, the adhesion of the adjacent silicone layer will be reduced by approximately 50%. The pattern of mold release/resist is applied to a first surface of a previously-cured sheet of silicone via the stencil, screen or other plate. This prepared sheet is then laid on top of an uncured sheet of silicone that may or may not be resident inside a mold. The combination of the cured silicone sheet with a stencil layer and the uncured silicone layer is then given time to cure. Upon curing, a sandwiched construct results having variable interface characteristics across the interface plane due to the stencil layer. This method, when repeated, with multiple layers builds up a specified thickness of simulated tissue with desired properties including variability of X-Y plane interface, properties along the Z-axis, in addition to and/or separate from material properties and visual characteristics. A higher percentage of area covered by dots of mold release/resist via the stencil, plate or screen will build up a tissue that feels softer and easier to pull apart. A lower percentage of area covered by mold release/resist dots via the stencil, plate or screen will build up a solid block that feels harder and is more monolithic and will be more difficult to cut or pull apart using surgical instruments.


In another variation, instead of applying resist or mold release via a stencil, plate or screen to a layer of cured silicone, silicone or other adhesive is applied via the stencil, plate, mask, or screen in a particular pattern or halftone to a layer of cured silicone which can then be used to join two previously cured silicone sheets creating two layers that are selectively adhered having variable adhesion along the interface plane and subsequently built up with additional layers to create a multiple layer construct having variable adhesion in the interfacing planes along the Z-axis. Hence, the stencil layer is a functional layer, the function of which may be selected from the group of adhesion, release, and color.


The pattern on the stencil, plate or screen is not limited to dots and material may be applied creating stencil layers for a simulated tissue structure where lines, webs, ovals, squares, curves or other shapes of various thicknesses and colors are created by the stencil layer, for example, to mimic vasculature, musculature, fatty layers or other complex organs and tissues in a two-dimensional layer and intercommunicating with adjacent layers in a three-dimensional construct in which structures transition and continue across multiple layers. This method is used to build an overall desired thickness of material of tissue structure to be used in surgical simulation.


In addition, each of these techniques, applying resist or adhesive using a stencil, screen or plate employing printmaking methods, can be used with textured sheets of silicone and casting dishes to further tailor the feel and response of the material. Also, color can be introduced to simulate different anatomical layers and constructs. The addition of color aids the user in navigation during surgical simulation as well as assessment after the simulation exercise is completed. For example, a surgeon practicing an incision will know that the incision through one or more base layers is too deep if a certain color such as red becomes visible wherein the red color is provided in a functional layer serving the function of a visual indicator for training purposes. Of course, color may be employed in at least the functional layer to provide various surgical markers, anatomy, and targets such as tumors and the like. Similarly, for example, after the simulation exercise is completed, an assessment of the layers can be made to ascertain the accuracy of a procedure for purposes of training and evaluation. For example, layers can be separated and examined to see if an incision penetrated too deeply or to see if care was taken to separate layers carefully without unnecessary cutting into unwanted anatomy.


In one variation, a block of simulated tissue is created using the resist method described above to create a block of simulated tissue comprising a plurality of layers where the layers gradually transition from flesh tone to white to red. When working with this multi-layered simulated tissue structure having a gradation of color and/or interface adhesion properties, dissection in the flesh tone and white layers would be positively regarding with respect to the simulation exercise. Also, positive regard would be attributed in the evaluation to respect for tissue techniques that illustrate the surgeon's skill to separate instead of cutting muscle fibers in the making of an incision through the abdomen for example. The variable adhesion characteristics of the simulated tissue model are used to facilitate the training of the separation of muscle fibers and other respect for tissue techniques. Colored layers can be used in the post-exercise assessment by examining the construct to see if cuts extend through the white layer(s) and into the red layer(s), for example. If the red layer(s), for example, have been cut, the surgeon and the assessor will know that they have gone too far and continued training is required. The present invention advantageously improves the feel and functionality of a simulated tissue structure especially in a training environment while providing live feedback to the surgeon and assessment means to the trainer especially in regard to dissection.


By creating stencils, screens, masks or plates such as silk screens or lithographic plates to be used to create simulated tissue for specific human or animal anatomy, specific, desirable properties can be achieved. By controlling the percent area and shape of adhesion or resist between two or more layers of silicone or KRATON or hydrogel, etc., a higher degree of realism can be achieved in surgical simulation and provide a way to train surgeons that was not previously possible.


Turning now to FIG. 15, there is shown a stencil 116 according to the present invention. The stencil 116 may also be called a plate, screen, mask or other similar article which is used interchangeably to describe the same stencil 116 throughout the specification. The stencil 116 includes a top surface 118 oppositely located and interconnected to a bottom surface 120. A plurality of holes 122 are formed in the stencil 116. The holes 122 extend through the top surface 118 to the bottom surface 120. The holes 122 are formed into a pattern as shown in FIG. 15. The pattern in FIG. 15 is uniform across the entire stencil 16. Resolution of the stencil 116 is defined as the number of lines per inch or the number of dots per inch measured parallel with the stencil's angle which lies in the plane of the stencil 116 such as a count taken along a zero angle that would be equated with nine o'clock of a clock drawn on the surface of the stencil or any other angle.


The holes 122 shown in FIG. 15 are circular in shape. However, the invention is not so limited and the holes 122 can be made to have any desired shape. For example, the holes 122 can be round, elliptical or square. For example, FIG. 16 illustrates a stencil 116 that has a plurality of holes 122 shaped like small curves. The repetitive pattern of curved holes 122 is provided evenly across the stencil 116 and mimic vasculature or other anatomically correct visual representation seen in real surgery. The pattern of holes 122 shown in FIG. 17 is limited to only a portion of the stencil 116 and, for example, is formed into a shape of a circle made of circular holes 122 in the center of the stencil 116 with three additional circular holes 122 in the center of the larger circle. The pattern and number of holes 122 are formed for a particular purpose in the creation of the simulated tissue structure. For example, the holes 122 may be shaped to represent an anatomical aspect of interest. An exemplary anatomical aspect may include vasculature such as capillaries and accordingly the stencil 116 would have a plurality of small curves formed randomly or in a pattern into the stencil 116. Such a stencil 116 may be used to meter a blue or red-colored silicone, for example, to provide a functional layer having representative structure as well as color. Another example may include a stencil 116 configured to impart features of muscle. As such, the holes 122 in the stencil 116 may be elongate, straight, substantially parallel to each other and angled to represent the muscular striations found in a layer of muscle. Such a stencil 116 may be employed to meter a layer of red silicone or hydrogel material or multiple layers may be formed by stacking a hydrogel layer metered via the stencil 116 and a colored silicone layer 115 directly over the hydrogel layer and separated by a cured layer of silicone in between the two functional layers formed by the stencil 116. Alternatively, layers of silicone are formed via the stencil 116 and sandwiched by one or more hydrogel layers. The functional layer made of hydrogel is configured to conduct electricity for simulating electro-surgery on the simulated tissue structure 110. A stencil 116 having a complex configuration of holes 122 of various shapes, patterns and arrangements are shown in FIG. 18. In FIG. 18, an even pattern of circular holes 122 appear in the upper right hand corner of the stencil 116 and a curved arrangement of holes 122 shaped like small curves are formed in the lower left hand corner of the stencil 116 and separated by a curve formed of circular holes 122. A custom stencil 116 is formed to create a custom aspect or feature in one layer of a multiple layer simulated tissue structure. Also, multiple stencils may be employed at the same interface to create a custom arrangement of properties for that interface. The properties include but are not limited to material characteristics, adhesion qualities, colors and shapes. The stencil 116 may have a thickness selected for the type, amount and desired thickness of the resulting stencil layer.


Turning now to FIG. 19, there is shown a first base layer 112 having a top surface 124 interconnected to and oppositely disposed from a bottom surface 126. The top surface 124 is substantially planar and parallel to the substantially planar bottom surface 126. A stencil 116 is shown spaced apart from the first layer 112 and oriented such that the bottom surface 120 of the stencil 116 faces the top surface 124 of the first layer 112. The stencil 116 includes a plurality of holes 122 that are round and formed into an even pattern across the stencil 116. The shape and pattern of the holes 122 are illustrative and not intended to be limiting. In the next step, illustrated in FIG. 20, the stencil 116 is laid onto the first sheet or first layer 112 such that the bottom surface 120 of the stencil 116 contacts or faces the top surface 124 of the first layer 112. A mold release, resist, grease, powder, lubrication, or other material is applied onto the stencil 116 such that the material passes through the holes 122 and is applied to the top surface 124 of the first layer 112. The stencil 116 is removed leaving behind a pattern of applied material or first stencil layer 15A on the first layer 112 as shown in FIG. 21 in the same pattern and shape as the pattern and shape of holes 122 on the stencil 16. In this example, the first stencil layer 15A includes a plurality of patterned dots. Alternatively, instead of release material, adhesive material may be employed such as glue or silicone or other adhesive and applied to the first layer 112 via the stencil 116. Furthermore, the material applied via the stencil 116 may be an electrically conductive material such has hydrogel or material having conductive properties/filament. Also, the material may include fiber or mesh to improve the suture-holding ability of the layer. The first layer 112 is a cured layer of silicone such as platinum cured room temperature vulcanization silicone (PCRTVS) rubber. The first layer 112 may also be made of KRATON, any elastomer or hydrogel or other conductive material or polymer material. The first stencil layer 115A is allowed to cure either before or after the stencil 116 is removed. FIG. 21 illustrates at least a portion of a simulated tissue structure 110 with the stencil 116 removed from the construct. Any of the material applied with the stencil 116 may include color appropriate to the anatomy being mimicked or the visual effect that is desired to be created employing transparencies and color combinations. In one aspect of the invention, the structure of FIG. 21 is a completed simulated tissue structure. In another aspect of the invention, one or more additional stencil layers 115 of the same or different material can be applied via the same or different stencil 116 either directly above the previously applied stencil layer 115A or offset from the previously applied stencil layer 115A.


The next step of the method of forming a simulated tissue structure according to the present invention is shown in FIG. 22 wherein the combination of the first base layer 112 and the one or more stencil layer 115A, such as the combination shown in FIG. 21, is placed in juxtaposition with a second base layer 114. In one variation, the second base layer 114 is uncured silicone, PCRTVS, that is applied onto the first stencil layer 115A and the top surface 124 of the first layer 112 and allowed to cure to form a sandwich comprising of the first layer 112 and the second layer 114 with the one or more first stencil layer 15A located therebetween. Still referencing FIG. 22, the second layer 114 includes a top surface 130 interconnected with a bottom surface 132. If the first stencil layer 115A includes an adhesive function, the first layer 112 and the second layer 114 will have strong points of adhesion in the location of the patterned first stencil layer 115A. If the first stencil layer 115A includes a resist or release functionable material, the first layer 112 and the second layer 114 will have locations where the first layer 112 and the second layer 114 are more readily and easily separable in the locations of the patterned stencil layer 115A. That is, the bottom surface 132 of the second layer 114 will be removable or separable from the top surface 124 of the first layer 112 in the locations of the first stencil layer 115A. The resulting simulated tissue structure 110 may be considered complete at this stage of manufacture or built up or progressed into a multi-layered structure by taking the completed sandwich of FIG. 22 and placing it in juxtaposition in parallel planar fashion with a stencil 116 as shown in FIG. 23. The stencil 116 may be the same or different stencil 116 than the one used in juxtaposition with the first layer 112. If the same stencil 116 is used it may be placed directly above or offset from the position of the previous stencil 116 or oriented at an angle relative to the previous stencil 116. The second stencil 116 may have a different pattern of holes 122 relative to the first stencil 116 and the holes 122 may have shapes and sizes that are different from the pattern, shapes and sizes of the previous stencil 116. The bottom surface 120 of the stencil 116 is placed in juxtaposition or in contact with the second layer 114 such that the bottom surface 120 of the stencil 116 faces the outer surface of the second layer 114. In one variation, the first stencil layer 115A is visible through the second layer 14 because the second layer 114 is transparent or translucent. With the stencil 116 in position, a mold release, resist, grease, powder, lubrication or other material is applied onto the stencil 116 such that the material passes through the holes 122 of the second stencil 116 and is applied to the top surface 130 of the second layer 114. The stencil 116 is removed leaving behind a pattern of applied material or second stencil layer 115B on the second layer 114 as shown in FIG. 24. In this example, the second stencil layer 115B includes a plurality of patterned dots that are offset from the first pattern of dots as a result of printing material via the first stencil 116. Alternatively, instead of release material, adhesive material may be employed such as glue or silicone or other adhesive and applied to the second layer 114 via the stencil 116. Furthermore, the material applied via the stencil 116 may be an electrically conductive material such has hydrogel or material having conductive filament. Also, the material may include fiber or mesh. The desired interface properties are applied via the stencil 116 to the second layer 114 for the interface between the second layer 114 and a third layer 134.


The next step of the method of forming the simulated tissue structure according to the present invention is shown in FIG. 25 wherein the combination of the first base layer 112, first stencil layer 115A, second base layer 114, and second stencil layer 115B is placed in juxtaposition with a third base layer 134. In one variation, the third base layer 134 is uncured silicone, PCRTVS, that is applied onto the second stencil layer 115B and the top surface 130 of the second base layer 114 and allowed to cure. The stencil 116 is removed to form a sandwich of the first layer 112 and the second layer 114 with the first stencil layer 115A located therebetween and a third layer 134 with a second stencil layer 115B located between the second layer 114 and the third layer 134. The third layer 134 includes a top surface 136 interconnected with a bottom surface 138 defining a substantially uniform thickness. If the second stencil layer 115B includes an adhesive, the second layer 114 and the third layer 134 will have strong points of adhesion in the location of the patterned second stencil layer 115B. If the second stencil layer 115B includes a resist or release material, the second layer 114 and the third layer 134 will have locations where the second layer 114 and the third layer 134 are more readily and easily separable in the locations of the dots of material of the second stencil layer 115B. That is, the bottom surface 138 of the third layer 134 will be removable or separable from the top surface 130 of the second layer 114. Hence, a custom arrangement of interface properties between multiple layers is created. The resulting simulated tissue structure 110 may be considered complete at this stage of manufacture or it may be built up or progressed further into a multi-layered structure by taking the completed sandwich of FIG. 25 and placing it in juxtaposition with another stencil 116 to form a third stencil layer 115C as shown in FIG. 26. Stencil layers 15A and 15B are visible in the sandwiched construction shown in FIG. 26 because the second layer 114 and the third layer 134 are transparent or translucent silicone layers in one variation.


Still referencing FIG. 26, a stencil 116 is laid onto the third sheet or third layer 134 such that the bottom surface 120 of the stencil 116 contacts or faces the top surface 136 of the third layer 134. A mold release, resist, grease, powder, lubrication or other material is applied onto the stencil 116 such that the material passes through the holes 122 and is applied to the top surface 136 of the third layer 134. The stencil 116 is removed leaving behind a pattern of applied material or third stencil layer 115C on the third layer 134 as shown in FIG. 26. In this example, the third stencil layer 115C includes a plurality of patterned dots that are offset slightly from the first stencil layer 115A and the second stencil layer 115B. Alternatively, instead of release material, adhesive material may be employed such as glue or silicone or other adhesive and applied to the third layer 134 via the stencil 116. Furthermore, the material applied via the stencil 116 may be an electrically conductive material such has hydrogel or material having conductive filament. Also, the material may include fiber or mesh. The third base layer 134 is a cured layer of silicone such as platinum cured room temperature vulcanization silicone (PCRTVS) rubber. The third layer 134 may also be made of KRATON, any elastomer or hydrogel or other conductive material or polymer material. The third stencil layer 115C is allowed to cure either before or after the stencil 116 is removed. FIG. 26 illustrates at least a portion of a simulated tissue structure 110 with the stencil 116 removed from the construct and a fourth base layer 140 applied. Any of the material applied with the stencil 116 may include color, shape and structure appropriate to the anatomy being mimicked or desired training and assessment goals for the simulated tissue structure 110. In one aspect of the invention, the structure of FIG. 26 is a completed simulated tissue structure. In another aspect of the invention, one or more additional stencil layer 115 of the same or different material or functional characteristic can be applied via the same or different stencil 116 either directly above the previously applied stencil layer 115C or offset from the previously applied stencil layer 115C. As shown in FIG. 26, an interesting pattern of color and/or other material characteristics develops and is built into the simulated tissue structure 110 and are enhanced by the transparency of the intermediate layers. The color pattern created by the different shapes of the stencil holes 122 emerges to mimic real live tissue colorations including tumor colorations that may appear dark in color. Furthermore, performance of surgical techniques, for example, in the location of one or more dark colored, black, brown or dark red dots, mold release in the same or surrounding locations of dots permits the simulated tumor locations to be realistically removed when practicing the procedure utilizing the simulated tissue structure 110 of the present invention. The location or pattern of release/resist or adhesive is predetermined and, in one variation, arranged to teach the surgeon the best path of excision to be taken with a scalpel or other instrument.


Still referencing FIG. 26, the sandwiched construct of the first layer 112, second layer 114 and first stencil layer 115A located therebetween and the third layer 134 and third stencil layer 115C located on the top surface 136 of the third layer 134 is placed in juxtaposition with a fourth layer 140. The fourth layer 140 may be a pre-formed, pre-cured sheet of platinum cured room temperature vulcanization silicone (PCRTVS) which is placed onto the top surface 136 of the third layer 134 to sandwich the third stencil layer 115C. Alternatively, the fourth layer 140 of uncured PCRTVS is poured onto the sandwiched construct and allowed to cure and depending on the material of the third stencil layer 115C either adhering strongly in the location of the third stencil layer 115C dots if an adhesive was or being readily separable in the location of the third stencil layer 115C dots if a release or resist was employed. The simulated tissue structure 110 shown in FIGS. 26 and 27 illustrate a final construction in one variation of the invention that includes a first layer 112, a second layer 114, a third layer 134 and a fourth layer 140 with a first stencil layer 115A located between the first layer 112 and second layer 114 and a second stencil layer 115B located between the second layer 114 and third layer 134 and a third stencil layer 115C located between the third layer 134 and the fourth layer 140. In one variation, the layers 112, 114, 134, 140 are transparent to keep the dots of the stencil layers 115A, 115B, 115C at least partially visible through the structure 110. Each of the stencil layers 115A, 115B, 115C may be formed of different colors. For example, the first stencil layer 115A is green, the second stencil layer 115B is blue and the third stencil layer 115C is red. The result is a moire pattern of RGB color space and shape. Also, in one variation, the uppermost layer, which in the case of the construct shown in FIGS. 26 and 27 is the fourth layer 140, is colored a flesh or tan color to be representational of skin. The layering of the simulated tissue structure 110 may continue as described with further additions of stencil layers 115 and base layers to create a sandwich stack of response appropriate sections and interfaces internal to the construct.


Turning now to FIG. 28, there is shown another variation of a stencil 116 having a plurality of holes 122 configured to mimic the arteries of a human omentum. The stencil 116 of FIG. 28 is used to lay down red-colored silicone in the unique shape of the omentum arteries via the plurality of holes 122 onto a first base layer (not shown). A second base layer may be employed to sandwich the arterial structures of the omentum therebetween to complete the simulated omentum. The stencil 116 is not limited to form arterial structures of the omentum but can be used with unique hole(s) 122 that mimic specific organ/tissue structures or unique shapes for a desired outcome.


Turning now to FIG. 29, there is shown another variation of a first stencil 116A in juxtaposition with a first base layer 112. The first base layer 112 is a planar sheet of silicone as described above. The first stencil 116A includes at least one hole 122. In particular, the first stencil 116A includes a first set of holes 122 comprising circular holes 122 and elongate holes 122A. Each elongate hole 122A has a first end 152 and a second end 154 defining a shape for applying a first stencil layer 115A of material such as silicone, adhesive, release, hydrogel, conductive material, fiberfill, mesh, filament or any other desired material. In FIG. 30, there is shown a first stencil layer 115A applied to the top surface of the first base layer 112. The holes 122A of the stencil 116A have formed a first stencil layer 115A having elongate structures as well as dots atop the first base layer 112 with each elongate structure having a first end 152A and a second end 154A. The simulated tissue structure is built-up with the overlay of a second base layer 114 over the first stencil layer 115A and first base layer 112 as shown in FIG. 31. The simulated tissue structure is further built-up with an application of a second stencil 1168 as shown in FIG. 32. The second stencil 1168 includes a plurality of holes 122. In particular, the second stencil 1168 includes a first set of holes 122 comprising circular holes 122 and elongate holes 122B. Each elongate hole 122B has a first end 156 and a second end 158 defining a shape for applying a second stencil layer 115B of material such as silicone, adhesive, release, hydrogel, conductive material, fiberfill, mesh, filament or any other desired material. In FIG. 33, there is shown a second stencil layer 115B applied to the top surface of the second base layer 114. The holes 122B of the second stencil 1168 have formed a second stencil layer 115B having elongate structures as well as dots atop the second base layer 114 with each elongate structure having a first end 156A and a second end 158A. FIG. 34 illustrates a third base layer 134 applied above the second stencil layer 115B and second base layer 114. FIG. 35 illustrates a third stencil 116C in juxtaposition with the construct of FIG. 34. The third stencil 116C includes a plurality of holes 122C including elongate structures each having a first end 160 and a second end 162. The third stencil 116C is placed atop the third base layer 134 to print a third stencil layer 115C as shown in FIG. 36. The third stencil layer 115C includes a plurality of dots and elongate structures, each having a first end 160A and a second end 1608. A fourth base layer 140 is then overlaid onto the third stencil layer 115C and the third base layer 134 as shown in FIG. 37 to complete the structure 110. A transparent view of the simulated tissue structure 110 in FIG. 38, shows how the plurality of dots formed by the stencil layers 115A, 115B, 115C, created a functional pattern of variable adhesion along the interfaces. Further, FIG. 38 illustrates how the plurality of printed dots of the stencil layers can produce a color pattern especially if any one or more of the base layers 112, 114, 134, 140 are transparent. The resulting unique color pattern creates a realistic view that increases the difficulty of locating anatomical features such as the elongate structures of the layers that may be representative of vasculature, arteries and ducts. The stencils 116A, 1168, 116C are configured to be used in sequential order to print anatomical structure on each base layer such that the anatomical structure not only propagates within the interface in which is printed in the X-Y plane, but also, appears to propagate in the X-Y plane of the entire simulated tissue structure when view along a Z-axis perpendicular to the X-Y plane of the simulated tissue structure as can be seen in FIG. 39. In one variation, the anatomical structure does not cross the base layers but merely overlap at their end points giving the appearance that the anatomical structure is continuous. For example, the first stencil 116A is used to print onto the first base layer 112 at least one anatomical structure that has a proximal end 152A and a distal end 154A and the second stencil 1168 is used to print onto the second base layer 114 a continuation of the at least one anatomical structure by printing onto the second base layer 114 the proximal end 156A at or adjacent to or overlapping with the distal end 154A of the anatomical structure previously printed so as to give the appearance of continuity of the anatomical structure across the interfaces when viewed along the Z-axis. Further, the third stencil 116C is used to print onto the third base layer 134 a continuation of the at least one anatomical structure by printing onto the third base layer 134 the proximal end 160A at or adjacent to or overlapping with the distal end 158A of the anatomical structure previously printed to give the appearance of continuity of the anatomical structure along the Z-axis. In another variation, the base layers 114A, 134A are provided with holes in the location of the overlapping ends of the anatomical structure such that when the anatomical structure is printed, wet silicone or other material used in the printing can pour through the hole in the base layers 114A, 134A to remove the discontinuity across the Z-axis. If hydrogel material or other conductive or non-conductive material is used in the printing of the anatomical structure, a conductive/non-conductive, fluidic circuit is printed that may then be connected to a ground and a power source for simulated electro-surgery or other.


The simulated tissue structure 110 formed according to the present invention advantageously introduces functional layers that are printed with a stencil between non-functional base or support layers. In the printing of functional layers, the stencil is used to pattern the material onto the base layers and then the stencil is removed. Each functional layer may serve one or more functional purpose. Also, multiple functional layers may be printed consecutively between two adjacent base layers or different functional layers may be printed at different interface locations. As described above, a stencil layer may serve the function of providing a mechanical interaction between the two base layers. For example, the location of adhesion and/or release as well as the degree of adhesion and/or release may be provided by a functional layer printed in a particular shape, pattern to provide a locus of mechanical interaction and the type of material printed whether release/adhesive or other material provides the type or strength of the mechanical property to create the customized property for that particular interface. Areas of weak mechanical connection can be provided by printing release/resist material or the like. Areas of strong mechanical attachment between base layers can be provided by printing uncured silicone onto a base layer of cured silicone, or printing adhesive, glue and the like. Another purpose served by a functional layer is providing a pathway for electrical conductivity such as for creating a simulated tissue structure suitable for practicing electro-surgery. In such a case, a hydrogel would be printed onto a base layer via the stencil. A fluidic circuit of hydrogel may be patterned to interconnect the dots or other pattern of the functional layer and to further connect the functional layer to a ground or power source. Creating a circuit may be provided by printing a conductive material other than hydrogel that includes conductive filaments or the like to impart pathways for conductivity as well as providing non-conductive areas/pathways. Another functional purpose that the functional layer may provide is suturability. In such a case, the stencil is used to lay down silicone with mesh, fiber and the like to strengthen areas for holding sutures. Another function for the stencil layer may be dissection. For example, a polyfill material may be employed and applied via a stencil onto a dry or wet silicone base layer to embed the polyfill material between the base layers in specific locations and then an adjacent wet layer of silicone may applied to create a functional interface that is easy to dissect or separate by cutting through the polyfill fibers. The functional layer may serve to provide realistic coloring to a layer or when used in conjunction with transparent or semi-transparent base layers where the color patterns can overlap with other color functional layers to create an overall effect. Also, as described above a functional layer may be used to lay down anatomical structures between and/or across base layers. Unique shapes representative of various anatomical structures may be formed using a stencil including but not limited to for example printing the shape and color of Toldt's fascia, omentum, anatomical landmarks/structures and the like. In another variation of the present invention, the stencil is not removed from the construct but left in to become an integral piece of the simulated tissue structure. For example, the stencil may be shaped to represent an anatomical bony structure or cartilage and located between two base layers in which an adjacent base layer is applied while uncured so as to interlock with the adjacent base layer to embed the stencil. In another variation, the stencil does not represent an anatomical structure when left in but is designed and configured to impart structural rigidity to the resulting structure. In yet another variation, the stencil is not employed to apply an intermediate functional layer between two base layers, but instead, serves to merely permit the application of an adjacent uncured silicone base layer through the holes of the stencil for attachment to the adjacent base layer in select areas defined by the stencil openings.


The simulated tissue structure 110 of the present invention is particularly suited for laparoscopic procedures and may be employed with a laparoscopic trainer; however, the invention is not so limited and the simulated tissue structure 110 of the present invention can be used alone to practice first entry surgical procedures equally effectively.


It is understood that various modifications may be made to the embodiments of the artificial tissue simulations and methods of making them disclosed herein. Therefore, the above description should not be construed as limiting, but merely as exemplifications of preferred embodiments. Those skilled in the art will envision other modifications within the scope and spirit of the present disclosure.

Claims
  • 1. A method of making a simulated tissue structure comprising the steps of: providing a mandrel having a proximal end, a distal end and a longitudinal axis wherein the distal end of the mandrel includes an interlocking portion having a length;providing an inner portion of a simulated tissue structure; the inner portion having a lumen sized and configured to receive the interlocking portion such that the entire length of the interlocking portion is located inside the lumen;placing the inner portion onto the mandrel;placing the interlocking portion of the mandrel into the lumen of the inner portion;rotating the mandrel about the longitudinal axis;applying uncured silicone onto the inner portion;curing the silicone to form an outer portion that surrounds the inner portion; andremoving the inner portion and the outer portion as one unit from the mandrel.
  • 2. The method of claim 1 wherein the step of providing a mandrel includes providing a mandrel having an anatomically-shaped portion distal to or proximal to the interlocking portion and the step of applying uncured silicone includes applying uncured silicone to the anatomically-shaped portion and inner portion to form the outer portion.
  • 3. The method of claim 2 wherein the anatomically shaped portion is shaped to mimic at least part of a human fallopian tube.
  • 4. The method of claim 1 further including the step of providing an artificial tumor between the inner portion and the outer portion.
  • 5. The method of claim 4 wherein the inner portion includes a dimple sized and configured for seating the artificial tumor.
  • 6. The method of claim 1 wherein the step of removing the inner portion and outer portion includes rolling the outer portion towards the inner portion.
  • 7. The method of claim 1 wherein the step of curing the silicone includes adhering the outer portion to the inner portion.
  • 8. The method of claim 1 wherein the inner portion has a diameter larger than the diameter of the outer portion.
  • 9. A method of making a simulated tissue structure comprising the steps of: providing a simulated anatomical structure;providing a mandrel having a longitudinal axis, a proximal end and a distal end, the mandrel being configured to removably attach to the simulated anatomical structure;connecting the simulated anatomical structure to the mandrel at a location along the longitudinal axis;rotating the mandrel and connected simulated anatomical structure;applying a second material in an uncured state to the mandrel and to the simulated anatomical structure;curing the second material onto the simulated anatomical structure and mandrel to form a simulated tissue structure in which the simulated anatomical structure is surrounded in a thin shell of the second material; the simulated tissue structure having at least one lumen defined by the second material cured onto the mandrel;attaching the second material to the simulated anatomical structure; andremoving the simulated anatomical structure with the attached second material.
  • 10. The method of claim 9 further including the step of providing a simulated tumor between the simulated anatomical structure and second material.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of International Application No. PCT/US2016/018697 entitled “Simulated tissue structures and methods” filed on Feb. 19, 2016 which claims priority to and benefit of U.S. Provisional Patent Application No. 62/118,179 entitled “Method of making simulated tissue using stencils” filed on Feb. 19, 2015 and U.S. Provisional Patent Application No. 62/119,542 entitled “Foam-on-mandrel method of making simulated anatomy” filed on Feb. 23, 2015 all of which are incorporated herein by reference in their entireties.

US Referenced Citations (480)
Number Name Date Kind
184573 Becker Nov 1876 A
2127774 Jacobs Aug 1938 A
2284888 Arneil, Jr. Jun 1942 A
2324702 Hoffman et al. Jul 1943 A
2345489 Lord Mar 1944 A
2495568 Coel Jan 1950 A
3766666 Stroop Oct 1973 A
3775865 Rowan Dec 1973 A
3789518 Chase Feb 1974 A
3921311 Beasley et al. Nov 1975 A
3991490 Markman Nov 1976 A
4001951 Fasse Jan 1977 A
4001952 Kleppinger Jan 1977 A
4321047 Landis Mar 1982 A
4323350 Bowden, Jr. Apr 1982 A
4332569 Burbank Jun 1982 A
4371345 Palmer et al. Feb 1983 A
4386917 Forrest Jun 1983 A
4459113 Boscaro Gatti et al. Jul 1984 A
4481001 Graham et al. Nov 1984 A
4596528 Lewis et al. Jun 1986 A
4726772 Amplatz Feb 1988 A
4737109 Abramson Apr 1988 A
4789340 Zikria Dec 1988 A
4832978 Lesser May 1989 A
4867686 Goldstein Sep 1989 A
4907973 Hon Mar 1990 A
4938696 Foster et al. Jul 1990 A
4940412 Blumenthal Jul 1990 A
5061187 Jerath Oct 1991 A
5083962 Pracas Jan 1992 A
5104328 Lounsbury Apr 1992 A
5149270 McKeown Sep 1992 A
5180308 Garito et al. Jan 1993 A
5230630 Burgett Jul 1993 A
5273435 Jacobson Dec 1993 A
5295694 Levin Mar 1994 A
5310348 Miller May 1994 A
5318448 Garito et al. Jun 1994 A
5320537 Watson Jun 1994 A
5358408 Medina Oct 1994 A
5368487 Medina Nov 1994 A
5380207 Siepser Jan 1995 A
5403191 Tuason Apr 1995 A
5425644 Szinicz Jun 1995 A
5425731 Daniel et al. Jun 1995 A
5472345 Eggert Dec 1995 A
5518406 Waters May 1996 A
5518407 Greenfield et al. May 1996 A
5520633 Costin May 1996 A
5541304 Thompson Jul 1996 A
5620326 Younker Apr 1997 A
5720742 Zacharias Feb 1998 A
5722836 Younker Mar 1998 A
5727948 Jordan Mar 1998 A
5743730 Clester et al. Apr 1998 A
5762458 Wang et al. Jun 1998 A
5769640 Jacobus et al. Jun 1998 A
5775916 Cooper et al. Jul 1998 A
5785531 Leung Jul 1998 A
5800178 Gillio Sep 1998 A
5803746 Barrie et al. Sep 1998 A
5807378 Jensen et al. Sep 1998 A
5810880 Jensen et al. Sep 1998 A
5814038 Jensen et al. Sep 1998 A
5850033 Mirzeabasov et al. Dec 1998 A
5855583 Wang et al. Jan 1999 A
5873732 Hasson Feb 1999 A
5873863 Komlosi Feb 1999 A
5908302 Goldfarb Jun 1999 A
5947743 Hasson Sep 1999 A
5951301 Younker Sep 1999 A
6080181 Jensen et al. Jun 2000 A
6083008 Yamada et al. Jul 2000 A
6113395 Hon Sep 2000 A
6234804 Yong May 2001 B1
6271278 Park et al. Aug 2001 B1
6336812 Cooper et al. Jan 2002 B1
6398557 Hoballah Jun 2002 B1
6413264 Jensen et al. Jul 2002 B1
6474993 Grund et al. Nov 2002 B1
6485308 Goldstein Nov 2002 B1
6488507 Stoloff et al. Dec 2002 B1
6497902 Ma Dec 2002 B1
6511325 Lalka et al. Jan 2003 B1
6517354 Levy Feb 2003 B1
6568941 Goldstein May 2003 B1
6589057 Keenan et al. Jul 2003 B1
6620174 Jensen et al. Sep 2003 B2
6654000 Rosenberg Nov 2003 B2
6659776 Aumann et al. Dec 2003 B1
6773263 Nicholls et al. Aug 2004 B2
6780016 Toly Aug 2004 B1
6817973 Merril et al. Nov 2004 B2
6820025 Bachmann et al. Nov 2004 B2
6854976 Suhr Feb 2005 B1
6857878 Chosack et al. Feb 2005 B1
6863536 Fisher et al. Mar 2005 B1
6866514 Von Roeschlaub et al. Mar 2005 B2
6887082 Shun May 2005 B2
6929481 Alexander et al. Aug 2005 B1
6939138 Chosack et al. Sep 2005 B2
6950025 Nguyen Sep 2005 B1
6960617 Omidian et al. Nov 2005 B2
6997719 Wellman et al. Feb 2006 B2
7008232 Brassel Mar 2006 B2
7018327 Conti Mar 2006 B1
7025064 Wang et al. Apr 2006 B2
7056123 Gregorio et al. Jun 2006 B2
7080984 Cohen Jul 2006 B1
7118582 Wang et al. Oct 2006 B1
7255565 Keegan Aug 2007 B2
7269532 David et al. Sep 2007 B2
7272766 Sakezles Sep 2007 B2
7300450 Vleugels et al. Nov 2007 B2
7364582 Lee Apr 2008 B2
7404716 Gregorio et al. Jul 2008 B2
7419376 Sarvazyan et al. Sep 2008 B2
7427199 Sakezles Sep 2008 B2
7431189 Shelton, IV et al. Oct 2008 B2
7441684 Shelton, IV et al. Oct 2008 B2
7465168 Allen et al. Dec 2008 B2
7467075 Humphries et al. Dec 2008 B2
7544062 Hauschild et al. Jun 2009 B1
7549866 Cohen et al. Jun 2009 B2
7553159 Arnal et al. Jun 2009 B1
7575434 Palakodeti Aug 2009 B2
7594815 Toly Sep 2009 B2
7621749 Munday Nov 2009 B2
7646901 Murphy et al. Jan 2010 B2
7648367 Makower et al. Jan 2010 B1
7648513 Green et al. Jan 2010 B2
7651332 Dupuis et al. Jan 2010 B2
7677897 Sakezles Mar 2010 B2
7775916 Mahoney Aug 2010 B1
7780451 Willobee et al. Aug 2010 B2
7802990 Korndorffer et al. Sep 2010 B2
7803151 Whitman Sep 2010 B2
7806696 Alexander et al. Oct 2010 B2
7819799 Merril et al. Oct 2010 B2
7833018 Alexander et al. Nov 2010 B2
7837473 Koh Nov 2010 B2
7850454 Toly Dec 2010 B2
7850456 Chosack et al. Dec 2010 B2
7854612 Frassica et al. Dec 2010 B2
7857626 Toly Dec 2010 B2
7866983 Hemphill et al. Jan 2011 B2
7931470 Alexander et al. Apr 2011 B2
7931471 Senagore et al. Apr 2011 B2
7988992 Omidian et al. Aug 2011 B2
7993140 Sakezles Aug 2011 B2
7997903 Hasson et al. Aug 2011 B2
8007281 Toly Aug 2011 B2
8007282 Gregorio et al. Aug 2011 B2
8016818 Ellis et al. Sep 2011 B2
8017107 Thomas et al. Sep 2011 B2
8021162 Sui Sep 2011 B2
8048088 Green et al. Nov 2011 B2
8083691 Goldenberg et al. Dec 2011 B2
8116847 Gattani et al. Feb 2012 B2
8137110 Sakezles Mar 2012 B2
8157145 Shelton, IV et al. Apr 2012 B2
8197464 Krever et al. Jun 2012 B2
8205779 Ma et al. Jun 2012 B2
8221129 Parry et al. Jul 2012 B2
8297982 Park et al. Oct 2012 B2
8308817 Egilsson et al. Nov 2012 B2
8323028 Matanhelia Dec 2012 B2
8323029 Toly Dec 2012 B2
8328560 Niblock et al. Dec 2012 B2
8342851 Speeg et al. Jan 2013 B1
8403674 Feygin et al. Mar 2013 B2
8403675 Stoianovici et al. Mar 2013 B2
8403676 Frassica et al. Mar 2013 B2
8408920 Speller Apr 2013 B2
8425234 Sakezles Apr 2013 B2
8439687 Morriss et al. May 2013 B1
8442621 Gorek et al. May 2013 B2
8454368 Ault et al. Jun 2013 B2
8459094 Yanni Jun 2013 B2
8459520 Giordano et al. Jun 2013 B2
8460002 Wang et al. Jun 2013 B2
8465771 Wan et al. Jun 2013 B2
8469715 Ambrozio Jun 2013 B2
8469716 Fedotov et al. Jun 2013 B2
8480407 Campbell et al. Jul 2013 B2
8480408 Ishii et al. Jul 2013 B2
8491309 Parry et al. Jul 2013 B2
8500753 Green et al. Aug 2013 B2
8512044 Sakezles Aug 2013 B2
8517243 Giordano et al. Aug 2013 B2
8521252 Diez Aug 2013 B2
8535062 Nguyen Sep 2013 B2
8544711 Ma et al. Oct 2013 B2
8556635 Toly Oct 2013 B2
8608483 Trotta et al. Dec 2013 B2
8613621 Hendrickson et al. Dec 2013 B2
8636520 Iwasaki et al. Jan 2014 B2
D699297 Bahsoun et al. Feb 2014 S
8641423 Gumkowski Feb 2014 B2
8647125 Johns et al. Feb 2014 B2
8678831 Trotta et al. Mar 2014 B2
8679279 Thompson et al. Mar 2014 B2
8696363 Gray et al. Apr 2014 B2
8708213 Shelton, IV et al. Apr 2014 B2
8708707 Hendrickson et al. Apr 2014 B2
8764449 Rios et al. Jul 2014 B2
8764452 Pravong et al. Jul 2014 B2
8800839 Beetel Aug 2014 B2
8801437 Mousques Aug 2014 B2
8801438 Sakezles Aug 2014 B2
8807414 Ross et al. Aug 2014 B2
8808004 Misawa et al. Aug 2014 B2
8808311 Heinrich et al. Aug 2014 B2
8814573 Nguyen Aug 2014 B2
8827988 Belson et al. Sep 2014 B2
8840628 Green et al. Sep 2014 B2
8870576 Millon et al. Oct 2014 B2
8888498 Bisaillon et al. Nov 2014 B2
8893946 Boudreaux et al. Nov 2014 B2
8911238 Forsythe Dec 2014 B2
8915742 Hendrickson et al. Dec 2014 B2
8945095 Blumenkranz et al. Feb 2015 B2
8961190 Hart et al. Feb 2015 B2
8966954 Ni et al. Mar 2015 B2
8968003 Hendrickson et al. Mar 2015 B2
9008989 Wilson et al. Apr 2015 B2
9017080 Placik Apr 2015 B1
9026247 White May 2015 B2
9050201 Egilsson et al. Jun 2015 B2
9056126 Hersel et al. Jun 2015 B2
9070306 Rappel et al. Jun 2015 B2
9087458 Shim et al. Jul 2015 B2
9096744 Wan et al. Aug 2015 B2
9117377 Shim et al. Aug 2015 B2
9119572 Gorek et al. Sep 2015 B2
9123261 Lowe Sep 2015 B2
9129054 Nawana et al. Sep 2015 B2
9196176 Hager et al. Nov 2015 B2
9226799 Lightcap et al. Jan 2016 B2
9257055 Endo et al. Feb 2016 B2
9265587 Vancamberg et al. Feb 2016 B2
9295468 Heinrich et al. Mar 2016 B2
9351714 Ross et al. May 2016 B2
9336694 Shim et al. Jun 2016 B2
9358682 Ruiz Morales Jun 2016 B2
9364224 Nicholas et al. Jun 2016 B2
9364279 Houser et al. Jun 2016 B2
9370361 Viola et al. Jun 2016 B2
9373270 Miyazaki Jun 2016 B2
9387276 Sun et al. Jul 2016 B2
9427496 Sun et al. Aug 2016 B2
9439649 Shelton, IV et al. Sep 2016 B2
9439733 Ha et al. Sep 2016 B2
9449532 Black et al. Sep 2016 B2
9468438 Baber et al. Oct 2016 B2
20010019818 Yong Sep 2001 A1
20020168619 Provenza Nov 2002 A1
20030031993 Pugh Feb 2003 A1
20030091967 Chosack et al. May 2003 A1
20030176770 Merril et al. Sep 2003 A1
20040005423 Dalton et al. Jan 2004 A1
20040126746 Toly Jul 2004 A1
20040248072 Gray et al. Dec 2004 A1
20050008997 Herman Jan 2005 A1
20050026125 Toly Feb 2005 A1
20050084833 Lacey et al. Apr 2005 A1
20050131390 Heinrich et al. Jun 2005 A1
20050142525 Cotin et al. Jun 2005 A1
20050192595 Green et al. Sep 2005 A1
20050196739 Moriyama Sep 2005 A1
20050196740 Moriyama Sep 2005 A1
20050214727 Stoianovici et al. Sep 2005 A1
20060046235 Alexander et al. Mar 2006 A1
20060252019 Burkitt et al. Nov 2006 A1
20060275741 Chewning et al. Dec 2006 A1
20070074584 Talarico et al. Apr 2007 A1
20070077544 Lemperle et al. Apr 2007 A1
20070078484 Talarico et al. Apr 2007 A1
20070148626 Ikeda Jun 2007 A1
20070166682 Yarin et al. Jul 2007 A1
20070197895 Nycz et al. Aug 2007 A1
20070225734 Bell et al. Sep 2007 A1
20070275359 Rotnes et al. Nov 2007 A1
20080032272 Palakodeti Feb 2008 A1
20080032273 Macnamara et al. Feb 2008 A1
20080052034 David et al. Feb 2008 A1
20080064017 Grundmeyer, III et al. Mar 2008 A1
20080076101 Hyde et al. Mar 2008 A1
20080097501 Blier Apr 2008 A1
20080108869 Sanders et al. May 2008 A1
20080187895 Sakezles Aug 2008 A1
20080188948 Flatt Aug 2008 A1
20080299529 Schaller Dec 2008 A1
20080317818 Griffith et al. Dec 2008 A1
20090068627 Toly Mar 2009 A1
20090142739 Wang et al. Jun 2009 A1
20090142741 Ault et al. Jun 2009 A1
20090143642 Takahashi et al. Jun 2009 A1
20090176196 Niblock et al. Jul 2009 A1
20090187079 Albrecht et al. Jul 2009 A1
20090246747 Buckman, Jr. Oct 2009 A1
20090298034 Parry et al. Dec 2009 A1
20090314550 Layton Dec 2009 A1
20100047752 Chan et al. Feb 2010 A1
20100094312 Ruiz Morales et al. Apr 2010 A1
20100099067 Agro Apr 2010 A1
20100167248 Ryan Jul 2010 A1
20100167249 Ryan Jul 2010 A1
20100167250 Ryan et al. Jul 2010 A1
20100167253 Ryan et al. Jul 2010 A1
20100167254 Nguyen Jul 2010 A1
20100196867 Geerligs et al. Aug 2010 A1
20100204713 Ruiz Morales Aug 2010 A1
20100209899 Park Aug 2010 A1
20100248200 Ladak Sep 2010 A1
20100258611 Smith et al. Oct 2010 A1
20100273136 Kandasami et al. Oct 2010 A1
20100279263 Duryea Nov 2010 A1
20100285094 Gupta Nov 2010 A1
20100324541 Whitman Dec 2010 A1
20110020779 Hannaford et al. Jan 2011 A1
20110046637 Patel et al. Feb 2011 A1
20110046659 Ramstein et al. Feb 2011 A1
20110087238 Wang et al. Apr 2011 A1
20110091855 Miyazaki Apr 2011 A1
20110137337 van den Dool et al. Jun 2011 A1
20110200976 Hou et al. Aug 2011 A1
20110207104 Trotta Aug 2011 A1
20110218550 Ma Sep 2011 A1
20110244436 Campo Oct 2011 A1
20110269109 Miyazaki Nov 2011 A2
20110281251 Mousques Nov 2011 A1
20110301620 Di Betta et al. Dec 2011 A1
20120015337 Hendrickson et al. Jan 2012 A1
20120015339 Hendrickson et al. Jan 2012 A1
20120016362 Heinrich et al. Jan 2012 A1
20120028231 Misawa et al. Feb 2012 A1
20120045743 Okano et al. Feb 2012 A1
20120065632 Shadduck Mar 2012 A1
20120082970 Pravong et al. Apr 2012 A1
20120100217 Green et al. Apr 2012 A1
20120115117 Marshall May 2012 A1
20120115118 Marshall May 2012 A1
20120116391 Houser et al. May 2012 A1
20120148994 Hori et al. Jun 2012 A1
20120164616 Endo et al. Jun 2012 A1
20120165866 Kaiser et al. Jun 2012 A1
20120172873 Artale et al. Jul 2012 A1
20120179072 Kegreiss Jul 2012 A1
20120202180 Stock et al. Aug 2012 A1
20120264096 Taylor et al. Oct 2012 A1
20120264097 Newcott et al. Oct 2012 A1
20120282583 Thaler et al. Nov 2012 A1
20120282584 Millon et al. Nov 2012 A1
20120283707 Giordano et al. Nov 2012 A1
20120288839 Crabtree Nov 2012 A1
20120308977 Tortola Dec 2012 A1
20130087597 Shelton, IV et al. Apr 2013 A1
20130101973 Hoke et al. Apr 2013 A1
20130105552 Weir et al. May 2013 A1
20130116668 Shelton, IV et al. May 2013 A1
20130157240 Hart et al. Jun 2013 A1
20130171288 Harders Jul 2013 A1
20130177890 Sakezles Jul 2013 A1
20130192741 Trotta et al. Aug 2013 A1
20130218166 Elmore Aug 2013 A1
20130224709 Riojas et al. Aug 2013 A1
20130245681 Straehnz et al. Sep 2013 A1
20130253480 Kimball et al. Sep 2013 A1
20130267876 Leckenby et al. Oct 2013 A1
20130282038 Dannaher et al. Oct 2013 A1
20130288216 Parry, Jr. et al. Oct 2013 A1
20130302771 Alderete Nov 2013 A1
20130324991 Clem et al. Dec 2013 A1
20130324999 Price et al. Dec 2013 A1
20140011172 Lowe Jan 2014 A1
20140017651 Sugimoto et al. Jan 2014 A1
20140030682 Thilenius Jan 2014 A1
20140038151 Hart Feb 2014 A1
20140051049 Jarc et al. Feb 2014 A1
20140072941 Hendrickson et al. Mar 2014 A1
20140087345 Breslin et al. Mar 2014 A1
20140087346 Breslin et al. Mar 2014 A1
20140087347 Tracy et al. Mar 2014 A1
20140087348 Tracy et al. Mar 2014 A1
20140088413 Von Bucsh et al. Mar 2014 A1
20140093852 Poulsen et al. Apr 2014 A1
20140093854 Poulsen et al. Apr 2014 A1
20140099858 Hernandez Apr 2014 A1
20140106328 Loor Apr 2014 A1
20140107471 Haider et al. Apr 2014 A1
20140156002 Thompson et al. Jun 2014 A1
20140162016 Matsui et al. Jun 2014 A1
20140170623 Jarstad et al. Jun 2014 A1
20140186809 Hendrickson et al. Jul 2014 A1
20140187855 Nagale et al. Jul 2014 A1
20140200561 Ingmanson et al. Jul 2014 A1
20140212861 Romano Jul 2014 A1
20140220527 Li et al. Aug 2014 A1
20140220530 Merkle et al. Aug 2014 A1
20140220532 Ghez et al. Aug 2014 A1
20140242564 Pravong et al. Aug 2014 A1
20140246479 Baber et al. Sep 2014 A1
20140248596 Hart et al. Sep 2014 A1
20140263538 Leimbach et al. Sep 2014 A1
20140272878 Shim et al. Sep 2014 A1
20140272879 Shim et al. Sep 2014 A1
20140275795 Little et al. Sep 2014 A1
20140275981 Selover et al. Sep 2014 A1
20140277017 Leimbach et al. Sep 2014 A1
20140303643 Ha et al. Oct 2014 A1
20140303646 Morgan et al. Oct 2014 A1
20140303660 Boyden et al. Oct 2014 A1
20140308643 Trotta et al. Oct 2014 A1
20140342334 Black et al. Nov 2014 A1
20140349266 Choi Nov 2014 A1
20140350530 Ross et al. Nov 2014 A1
20140357977 Zhou Dec 2014 A1
20140370477 Black et al. Dec 2014 A1
20140371761 Juanpera Dec 2014 A1
20140378995 Kumar et al. Dec 2014 A1
20150031008 Black et al. Jan 2015 A1
20150037773 Quirarte Catano Feb 2015 A1
20150038613 Sun et al. Feb 2015 A1
20150076207 Boudreaux et al. Mar 2015 A1
20150086955 Poniatowski et al. Mar 2015 A1
20150132732 Hart et al. May 2015 A1
20150132733 Garvik et al. May 2015 A1
20150135832 Blumenkranz et al. May 2015 A1
20150148660 Weiss et al. May 2015 A1
20150164598 Blumenkranz et al. Jun 2015 A1
20150187229 Wachli et al. Jul 2015 A1
20150194075 Rappel et al. Jul 2015 A1
20150202299 Burdick et al. Jul 2015 A1
20150209035 Zemlock Jul 2015 A1
20150209059 Trees et al. Jul 2015 A1
20150209573 Hibner et al. Jul 2015 A1
20150228206 Shim et al. Aug 2015 A1
20150262511 Lin et al. Sep 2015 A1
20150265431 Egilsson et al. Sep 2015 A1
20150272571 Leimbach et al. Oct 2015 A1
20150272574 Leimbach et al. Oct 2015 A1
20150272580 Leimbach et al. Oct 2015 A1
20150272581 Leimbach et al. Oct 2015 A1
20150272583 Leimbach et al. Oct 2015 A1
20150272604 Chowaniec et al. Oct 2015 A1
20150332609 Alexander Nov 2015 A1
20150358426 Kimball et al. Dec 2015 A1
20150371560 Lowe Dec 2015 A1
20150374378 Giordano et al. Dec 2015 A1
20150374449 Chowaniec et al. Dec 2015 A1
20160000437 Giordano et al. Jan 2016 A1
20160022374 Haider et al. Jan 2016 A1
20160030240 Gonenc et al. Feb 2016 A1
20160031091 Popovic et al. Feb 2016 A1
20160058534 Derwin et al. Mar 2016 A1
20160066909 Baber et al. Mar 2016 A1
20160070436 Thomas et al. Mar 2016 A1
20160073928 Soper et al. Mar 2016 A1
20160074103 Sartor Mar 2016 A1
20160098933 Reiley et al. Apr 2016 A1
20160104394 Miyazaki Apr 2016 A1
20160117956 Larsson et al. Apr 2016 A1
20160125762 Becker et al. May 2016 A1
20160133158 Sui et al. May 2016 A1
20160140876 Jabbour et al. May 2016 A1
20160194378 Cass et al. Jul 2016 A1
20160199059 Shelton, IV et al. Jul 2016 A1
20160220150 Sharonov Aug 2016 A1
20160220314 Huelman et al. Aug 2016 A1
20160225288 East et al. Aug 2016 A1
20160232819 Hofstetter et al. Aug 2016 A1
20160235494 Shelton, IV et al. Aug 2016 A1
20160256187 Shelton, IV et al. Sep 2016 A1
20160256229 Morgan et al. Sep 2016 A1
20160262736 Ross et al. Sep 2016 A1
20160262745 Morgan et al. Sep 2016 A1
20160293055 Hofstetter Oct 2016 A1
20160296144 Gaddam et al. Oct 2016 A1
Foreign Referenced Citations (77)
Number Date Country
2421706 Feb 2001 CN
2751372 Jan 2006 CN
2909427 Jun 2007 CN
101313842 Dec 2008 CN
101528780 Sep 2009 CN
201364679 Dec 2009 CN
201955979 Aug 2011 CN
102458496 May 2012 CN
202443680 Sep 2012 CN
202563792 Nov 2012 CN
202601055 Dec 2012 CN
202694651 Jan 2013 CN
103050040 Apr 2013 CN
203013103 Jun 2013 CN
203038549 Jul 2013 CN
203338651 Dec 2013 CN
203397593 Jan 2014 CN
203562128 Apr 2014 CN
102596275 Jun 2014 CN
103845757 Jun 2014 CN
103886797 Jun 2014 CN
103396562 Jul 2015 CN
105194740 Dec 2015 CN
105504166 Apr 2016 CN
9102218 May 1991 DE
41 05 892 Aug 1992 DE
44 14 832 Nov 1995 DE
19716341 Sep 2000 DE
1 024 173 Aug 2000 EP
2 218 570 Aug 2010 EP
2 691 826 Dec 1993 FR
2 917 876 Dec 2008 FR
2488994 Sep 2012 GB
10 211160 Aug 1998 JP
2001005378 Jan 2001 JP
2009236963 Oct 2009 JP
3162161 Aug 2010 JP
2013127496 Jun 2013 JP
101231565 Feb 2013 KR
PA 02004422 Nov 2003 MX
106230 Sep 2013 PT
WO 199406109 Mar 1994 WO
WO 1996042076 Dec 1996 WO
WO 199858358 Dec 1998 WO
WO 199901074 Jan 1999 WO
WO 200036577 Jun 2000 WO
WO 200238039 May 2002 WO
WO 2002038039 May 2002 WO
WO 2004032095 Apr 2004 WO
WO 2004082486 Sep 2004 WO
WO 2005071639 Aug 2005 WO
WO 2006083963 Aug 2006 WO
WO 2007068360 Jun 2007 WO
WO 2008021720 Feb 2008 WO
WO 2008103383 Aug 2008 WO
WO 2009000939 Dec 2008 WO
WO 2009089614 Jul 2009 WO
WO 2010094730 Aug 2010 WO
WO 2011035410 Mar 2011 WO
WO 2011046606 Apr 2011 WO
WO 2011127379 Oct 2011 WO
WO 2011151304 Dec 2011 WO
WO 2012149606 Nov 2012 WO
WO 2012168287 Dec 2012 WO
WO 2012175993 Dec 2012 WO
WO 2013048978 Apr 2013 WO
WO 2013103956 Jul 2013 WO
WO 2014022815 Feb 2014 WO
WO 2014093669 Jun 2014 WO
WO 2014197793 Dec 2014 WO
WO 201 51 4881 Oct 2015 WO
WO 2016138528 Sep 2016 WO
WO 201 61 8341 Nov 2016 WO
WO 2016198238 Dec 2016 WO
WO 2016201085 Dec 2016 WO
WO 2017031214 Feb 2017 WO
WO 2017042301 Mar 2017 WO
Non-Patent Literature Citations (74)
Entry
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2016/036664, entitled “Hysterectomy Model,” dated Dec. 21, 2017, 10 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2016/018697, entitled “Simulated Tissue Structures and Methods,” dated Aug. 31, 2017, 14 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2016/055148, entitled “Hysterectomy Model,” dated Apr. 12, 2018, 12 pgs.
European Patent Office, Examination Report for European Application No. 14733949.3 titled “Gallbladder Model,” dated Dec. 21, 2016, 6 pgs.
European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2016/062669 titled “Simulated Dissectible Tissue,” dated Apr. 5, 2017, 19 pgs.
European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2017/020389 titled “Simulated Tissue Cartridge”, dated May 24, 2017, 13 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability and Written Opinion for International Application No. PCT/US2015/059668, entitled “Simulated Tissue Models and Methods,” dated May 26, 2017, 16 pgs.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2018/018895, entitled “Synthetic Tissue Structures for Electrosurgical Training and Simulation,” dated May 17, 2018, 12 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2016/062669, entitled “Simulated Dissectible Tissue,” dated May 31, 2018, 11 pgs.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2018/018036, entitled “Laparoscopic Training System,” dated Jun. 8, 2018, 13 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2016/0032292, entitled “Synthetic Tissue Structures for Electrosurgical Training and Simulation,” dated Nov. 23, 2017, 2017, 8 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2016/034591, entitled “Surgical Training Model for Laparoscopic Procedures,” dated Dec. 7, 2017, 2017, 14 pgs.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2017/039113, entitled “Simulated Abdominal Wall,” dated Aug. 7, 2017, 13 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2016/041852, entitled “Simulated Dissectible Tissue,” dated Jan. 25, 2018, 12 pgs.
European Patent Office, Extended European Search Report for European Patent Application No. EP 17202365.7, titled “Gallbladder Model”, dated Jan. 31, 2018, 8 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2016/043277, entitled “Appendectomy Model,” dated Feb. 1, 2018, 9 pgs.
European Patent Office, Invitation to Pay Additional Fees for International Application No. PCT/US2016/062669, titled “Simulated Dissectible Tissue”, dated Feb. 10, 2017, 8 pgs.
European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2016/055148 titled “Hysterectomy Model”, dated Feb. 28, 2017, 12 pgs.
Society of Laparoendoscopic Surgeons, “Future Technology Session: The Edge of Innovation in Surgery, Space, and Business,” http://www.laparoscopytoday.com/endourology/page/2/ , Figure 1B: http://laparoscopy.blogs.com/laparoscopy_today/images/6-1/6-1VlaovicPicB.jpg , Sep. 5-8, 2007, 10 pgs.
European Patent Office, International Search Report for International Application No. PCT/US2011/053859 A3, dated Apr. 5, 2012, entitled “Portable Laparoscopic Trainer,” 8 pgs.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2012/60997, entitled “Simulated Tissue Structure for Surgical Training,” dated Mar. 7, 2013, 8 pgs.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2012/070971, entitled “Advanced Surgical Simulation,” dated Mar. 18, 2013, 10 pgs.
Human Patient Simulator, Medical Education Technologies, Inc., http://www.meti.com (1999) all, printed Apr. 12, 2013, 24 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability and Written Opinion for International Application No. PCT/US2011/053859, entitled “Portable Laparoscopic Trainer,” dated Apr. 2, 2013, 9 pgs.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2013/062363, entitled “Surgical Training Model for Laparoscopic Procedures,” dated Jan. 22, 2014, 11 pgs.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2013/061949, entitled “Surgical Training Model for Laparoscopic Procedures,” dated Feb. 17, 2014, 7 pgs.
Anonymous: Realsim Systems—LTS2000, Sep. 4, 2005, pp. 1-2, XP055096193, Retrieved from the Internet: URL:https://web.archive.org/web/2005090403; 3030/http://www.realsimsystems.com/exersizes.htm (retrieved on Jan. 14, 2014).
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2013/062269, entitled “Surgical Training Model for Transluminal Procedures,” dated Feb. 17, 2014, 8 pgs.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2013/061557, entitled “Surgical Training Model for Laparoscopic Procedures,” dated Feb. 10, 2014, 9 pgs.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2013/061728, entitled “Surgical Training Model for Laparoscopic Procedures,” dated Oct. 18, 2013, 9 pgs.
Limps and Things, EP Guildford MATTU Hernia Trainer, http://limbsandthings.com/us/products/tep-guildford-mattu-hernia-trainer/, printed May 29, 2014, 11 pgs.
Simulab, Hernia Model, http://www.simulab.com/product/surgery/open/hernia model, printed printed May 29, 2014, 4 pgs.
McGill Laparoscopic Inguinal Hernia Simulator, Novel Low-Cost Simulator for Laparoscopic Inguinal Hernia Repair, Feb. 8, 2011, 1 pg.
University of Wisconsin-Madison Biomedical Engineering, Inguinal Hernia Model, http://bmedesign.engr.wisc.edu/projects/s10/hernia_model/, printed May 29, 2014, 62 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2012/070971, entitled “Advanced Surgical Simulation,” dated Jun. 24, 2014, 7 pgs.
European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2014/038195, entitled “Hernia Model”, dated Oct. 15, 2014, 20 pgs.
European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2014/048027, entitled “First Entry Model”, dated Oct. 17, 2014, 10 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2012/060997, entitled “Simulated Tissue Structure for Surgical Training” dated Apr. 22, 2014, 6 pgs.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2014/019840, entitled “Advanced Surgical Simulation Constructions and Methods,” dated Jul. 4, 2014, 8 pgs.
Kurashima, et al, “A tool for training and evaluation of Laparoscopic inguinal hernia repair; the Global Operative Assessment of Laparoscopic Skills-Groin Hernia” American Journal of Surgery, Paul Hoeber, New York, NY, US vol. 201, No. 1, Jan. 1 2011, pp. 54-61 XP027558745.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2014/042998, entitled “Gallbladder Model,” dated Jan. 7, 2015, 20 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability, for PCT application No. PCT/US2013/053497, entitled Simulated Stapling and Energy Based Ligation for Surgical Training, dated Feb. 12, 2015, 6 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2013/062363, entitled “Surgical Training Model for Laparoscopic Procedures,” dated Apr. 9, 2015, 9 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2013/062269, entitled “Surgical Training Model for Laparoscopic Procedures,” dated Apr. 9, 2015, 6 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2013/061557, entitled “Surgical Training Model for Laparoscopic Procedures,” dated Apr. 9, 2015, 6 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2013/061728, entitled “Surgical Training Model for Laparoscopic Procedures,” dated Apr. 9, 2015, 7 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2013/061949, entitled “Surgical Training Model for Laparoscopic Procedures,” dated Apr. 9, 2015, 6 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2014/019840, entitled “Simulated Tissue Structure for Surgical Training,” dated Sep. 11, 2015, 8 pgs.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2015/020574, entitled “Advanced First Entry Model for Surgical Simulation,” dated Jun. 1, 2015, 12 pgs.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2015/022774, entitled “Simulated Dissectible Tissue,” dated Jun. 11, 2015, 13 pgs.
Anonymous: Silicone rubber-from Wikipedia, the free encyclopedia, pp. 1-6, XP055192375, Retrieved from the Internet: URL:http://en.wikipedia.org/w.index.php?title=Silicone_rubber&oldid=596456058 (retrieved on May 29, 2015).
Lamouche, et al., “Review of tissue simulating phantoms with controllable optical, mechanical and structural properties for use in optical coherence tomography,” Biomedical Optics Express, Jun. 1, 2012, 18 pgs., vol. 3, No. 6.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2014/038195, entitled “Hernia Model,” dated Nov. 26, 2015, 16 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2014/042998, entitled “Gallbladder Model,” dated Dec. 30, 2015, 15 pgs.
European Patent Office, International Search Report and Written Opinion for International Application No. PCT/US2013/053497, titled “Simulated Stapling and Energy Based Ligation for Surgical Training,” dated Nov. 5, 2013, 8 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2014/048027, entitled “First Entry Model,” dated Feb. 4, 2016, 8 pgs.
European Patent Office, International Search Report and Written Opinion for International Application No. PCT/US2015/059668, entitled “Simulated Tissue Models and Methods,” dated Apr. 26, 2016, 20 pgs.
Australian Patent Office, Patent Examination Report No. 1 for Australian Application No. 2012358851, titled “Advanced Surgical Simulation,” dated May 26, 2016, 3 pgs.
Miyazaki Enterprises, “Miya Model Pelvic Surgery Training Model and Video,” www.miyazakienterprises, printed Jul. 1, 2016, 1 pg.
European Patent Office, International Search Report and Written Opinion for International Application No. PCT/US2016/032292, entitled “Synthetic Tissue Structures for Electrosurgical Training and Simulation,” dated Jul. 14, 2016, 11 pgs.
European Patent Office, International Search Report and Written Opinion for International Application No. PCT/US2016/018697, entitled “Simulated Tissue Structures and Methods,” dated Jul. 14, 2016, 21 pgs.
European Patent Office, International Search Report and Written Opinion for International Application No. PCT/US2016/034591, entitled “Surgical Training Model for Laparoscopic Procedures,” dated Aug. 8, 2016, 18 pgs.
European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2016/036664, entitled “Hysterectomy Model”, dated Aug. 19, 2016, 15 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2015/020574, entitled “Advanced First Entry Model for Surgical Simulation,” dated Sep. 22, 2016, 9 pgs.
European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2016/0043277 titled “Appendectomy Model”, dated Oct. 4, 2016, 12 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2015/022774, titled “Simulated Dissectible Tissue,” dated Oct. 6, 2016, 9 pgs.
European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2016/041852 titled “Simulated Dissectible Tissue”, dated Oct. 13, 2016, 12 pgs.
3D-MED Corporation, “Validated Training Course for Laparoscopic Skills,” https://www.3-dmed.com/sites/default/files/product-additional/product-spec/Validated%20Training%20Course%20Laparoscopic%20Skills.docx_3.pdf , printed Aug. 23, 2016, pp. 1-6.
3D-MED Corporation, “Loops and Wire #1,” https://www.3-dmed.com/product/loops-and-wire-1 , printed Aug. 23, 2016, 4 pgs.
Barrier, et al., “A Novel and Inexpensive Vaginal Hysterectomy Simulatory,” Simulation in Healthcare: The Journal of the Society for Simulation in Healthcare, vol. 7, No. 6, Dec. 1, 2012, pp. 374-379.
European Patent Office, Extended European Search Report for European Patent Application No. EP 18184147.9, titled “First Entry Model,” dated Nov. 7, 2018, 7 pgs.
European Patent Office, Extended European Search Report for European Patent Application No. EP 18177751.7, titled “Portable Laparoscopic Trainer,” dated Jul. 13, 2018, 8 pgs.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2018/034705, entitled “Laparoscopic Training System,” dated Aug. 20, 2018, 14 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2017/020389, entitled “Simulated Tissue Cartridge,” dated Sep. 13, 2018, 8 pgs.
Related Publications (1)
Number Date Country
20160293055 A1 Oct 2016 US
Provisional Applications (2)
Number Date Country
62119542 Feb 2015 US
62118179 Feb 2015 US
Continuations (1)
Number Date Country
Parent PCT/US2016/018697 Feb 2016 US
Child 15185360 US